Apple (AAPL) 10-Q 27 Apr 16 2016 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares shares in Thousands	6 Months Ended
	Mar. 26, 2016	Apr. 08, 2016
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 26, 2016
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	Q2
Trading Symbol	AAPL
Entity Registrant Name	APPLE INC
Entity Central Index Key	320,193
Current Fiscal Year End Date	--09-24
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		5,477,425

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Millions	3 Months Ended		6 Months Ended
	Mar. 26, 2016	Mar. 28, 2015	Mar. 26, 2016	Mar. 28, 2015
Net sales	$ 50,557	$ 58,010	$ 126,429	$ 132,609
Cost of sales	30,636	34,354	76,085	79,212
Gross margin	19,921	23,656	50,344	53,397
Operating expenses:
Research and development	2,511	1,918	4,915	3,813
Selling, general and administrative	3,423	3,460	7,271	7,060
Total operating expenses	5,934	5,378	12,186	10,873
Operating income	13,987	18,278	38,158	42,524
Other income/(expense), net	155	286	557	456
Income before provision for income taxes	14,142	18,564	38,715	42,980
Provision for income taxes	3,626	4,995	9,838	11,387
Net income	$ 10,516	$ 13,569	$ 28,877	$ 31,593
Earnings per share:
Basic	$ 1.91	$ 2.34	$ 5.22	$ 5.43
Diluted	$ 1.90	$ 2.33	$ 5.19	$ 5.39
Shares used in computing earnings per share:
Basic	5,514,381	5,793,799	5,536,656	5,818,441
Diluted	5,540,886	5,834,858	5,567,506	5,858,330
Cash dividends declared per share	$ 0.52	$ 0.47	$ 1.04	$ 0.94

CONDENSED CONSOLIDATED STATEME3

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 26, 2016	Mar. 28, 2015	Mar. 26, 2016	Mar. 28, 2015
Net income	$ 10,516	$ 13,569	$ 28,877	$ 31,593
Other comprehensive income/(loss):
Change in foreign currency translation, net of tax	120	(180)	18	(246)
Change in unrealized gains/losses on derivative instruments:
Change in fair value of derivatives, net of tax	(178)	1,037	109	3,019
Adjustment for net (gains)/losses realized and included in net income, net of tax	(528)	(739)	(973)	(1,304)
Total change in unrealized gains/losses on derivative instruments, net of tax	(706)	298	(864)	1,715
Change in unrealized gains/losses on marketable securities:
Change in fair value of marketable securities, net of tax	969	593	47	137
Adjustment for net (gains)/losses realized and included in net income, net of tax	49	36	96	22
Total change in unrealized gains/losses on marketable securities, net of tax	1,018	629	143	159
Total other comprehensive income/(loss)	432	747	(703)	1,628
Total comprehensive income	$ 10,948	$ 14,316	$ 28,174	$ 33,221

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Mar. 26, 2016	Sep. 26, 2015
Current assets:
Cash and cash equivalents	$ 21,514	$ 21,120
Short-term marketable securities	33,769	20,481
Accounts receivable, less allowances of $60 and $63, respectively	12,229	16,849
Inventories	2,281	2,349
Vendor non-trade receivables	7,595	13,494
Other current assets	10,204	15,085
Total current assets	87,592	89,378
Long-term marketable securities	177,645	164,065
Property, plant and equipment, net	23,203	22,471
Goodwill	5,249	5,116
Acquired intangible assets, net	3,843	3,893
Other non-current assets	7,745	5,556
Total assets	305,277	290,479
Current liabilities:
Accounts payable	25,098	35,490
Accrued expenses	23,208	25,181
Deferred revenue	9,461	8,940
Commercial paper	7,998	8,499
Current portion of long-term debt	2,500	2,500
Total current liabilities	68,265	80,610
Deferred revenue, non-current	3,322	3,624
Long-term debt	69,374	53,463
Other non-current liabilities	33,859	33,427
Total liabilities	$ 174,820	$ 171,124
Commitments and contingencies
Shareholders' equity:
Common stock and additional paid-in capital, $0.00001 par value: 12,600,000 shares authorized; 5,478,446 and 5,578,753 shares issued and outstanding, respectively	$ 29,484	$ 27,416
Retained earnings	102,021	92,284
Accumulated other comprehensive income/(loss)	(1,048)	(345)
Total shareholders' equity	130,457	119,355
Total liabilities and shareholders' equity	$ 305,277	$ 290,479

CONDENSED CONSOLIDATED BALANCE5

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Millions	Mar. 26, 2016	Sep. 26, 2015
Accounts receivable, allowances	$ 60	$ 63
Common stock, par value	$ 0.00001	$ 0.00001
Common stock, shares authorized	12,600,000,000	12,600,000,000
Common stock, shares issued	5,478,446,000	5,578,753,000
Common stock, shares outstanding	5,478,446,000	5,578,753,000

CONDENSED CONSOLIDATED STATEME6

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	6 Months Ended
	Mar. 26, 2016	Mar. 28, 2015
Cash and cash equivalents, beginning of the period	$ 21,120	$ 13,844
Operating activities:
Net income	28,877	31,593
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization	5,431	5,054
Share-based compensation expense	2,126	1,815
Deferred income tax expense	3,092	1,879
Changes in operating assets and liabilities:
Accounts receivable, net	4,620	6,555
Inventories	68	(285)
Vendor non-trade receivables	5,899	2,500
Other current and non-current assets	300	2,448
Accounts payable	(9,475)	(5,428)
Deferred revenue	219	993
Other current and non-current liabilities	(2,093)	5,679
Cash generated by operating activities	39,064	52,803
Investing activities:
Purchases of marketable securities	(86,242)	(92,523)
Proceeds from maturities of marketable securities	9,148	5,871
Proceeds from sales of marketable securities	50,051	48,924
Payments made in connection with business acquisitions, net	(140)	(115)
Payments for acquisition of property, plant and equipment	(5,948)	(5,586)
Payments for acquisition of intangible assets	(657)	(155)
Other	(322)	88
Cash used in investing activities	(34,110)	(43,496)
Financing activities:
Proceeds from issuance of common stock	247	309
Excess tax benefits from equity awards	264	357
Payments for taxes related to net share settlement of equity awards	(751)	(608)
Payments for dividends and dividend equivalents	(5,871)	(5,544)
Repurchase of common stock	(13,530)	(12,000)
Proceeds from issuance of term debt, net	15,584	11,332
Change in commercial paper, net	(503)	(2,508)
Cash used in financing activities	(4,560)	(8,662)
Increase in cash and cash equivalents	394	645
Cash and cash equivalents, end of the period	21,514	14,489
Supplemental cash flow disclosure:
Cash paid for income taxes, net	6,630	7,058
Cash paid for interest	$ 565	$ 220

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Mar. 26, 2016
Summary of Significant Accounting Policies	Note 1 – Summary of Significant Accounting Policies Apple Inc. and its wholly-owned subsidiaries (collectively “Apple” or the “Company”) designs, manufactures and markets mobile communication and media devices, personal computers and portable digital music players, and sells a variety of related software, services, accessories, networking solutions and third-party digital content and applications. The Company sells its products worldwide through its retail stores, online stores and direct sales force, as well as through third-party cellular network carriers, wholesalers, retailers and value-added resellers. In addition, the Company sells a variety of third-party Apple-compatible products, including application software and various accessories through its online and retail stores. The Company sells to consumers, small and mid-sized businesses and education, enterprise and government customers. Basis of Presentation and Preparation The accompanying condensed consolidated financial statements include the accounts of the Company. Intercompany accounts and transactions have been eliminated. In the opinion of the Company’s management, the condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. The preparation of these condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the amounts reported in these condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. Certain prior period amounts in the condensed consolidated financial statements have been reclassified to conform to the current period’s presentation. These condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company’s annual consolidated financial statements and the notes thereto included in its Annual Report on Form 10-K for the fiscal year ended September 26, 2015 (the “2015 Form 10-K”). The Company’s fiscal year is the 52 or 53-week period that ends on the last Saturday of September. An additional week is included in the first fiscal quarter approximately every six years to realign fiscal quarters with calendar quarters. The Company’s fiscal years 2016 and 2015 each include 52 weeks. Unless otherwise stated, references to particular years, quarters or months refer to the Company’s fiscal years ended in September and the associated quarters or months of those fiscal years. During the first quarter of 2016, the Company adopted an accounting standard that simplified the presentation of deferred taxes by requiring deferred tax assets and liabilities be classified as noncurrent in a classified statement of financial position. The Company has adopted this accounting standard prospectively; accordingly, the prior period amounts in the Company’s Condensed Consolidated Balance Sheets within this Quarterly Report on Form 10-Q were not adjusted to conform to the new accounting standard. The adoption of this accounting standard was not material to the Company’s condensed consolidated financial statements. Earnings Per Share Basic earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding stock options, shares to be purchased under the Company’s employee stock purchase plan, unvested restricted stock and unvested restricted stock units (“RSUs”). The dilutive effect of potentially dilutive securities is reflected in diluted earnings per share by application of the treasury stock method. Under the treasury stock method, an increase in the fair market value of the Company’s common stock can result in a greater dilutive effect from potentially dilutive securities. The following table shows the computation of basic and diluted earnings per share for the three- and six-month periods ended March 26, 2016 and March 28, 2015 (net income in millions and shares in thousands): Three Months Ended Six Months Ended March 26, 2016 March 28, 2015 March 26, 2016 March 28, 2015 Numerator: Net income $ 10,516 $ 13,569 $ 28,877 $ 31,593 Denominator: Weighted-average shares outstanding 5,514,381 5,793,799 5,536,656 5,818,441 Effect of dilutive securities 26,505 41,059 30,850 39,889 Weighted-average diluted shares 5,540,886 5,834,858 5,567,506 5,858,330 Basic earnings per share $ 1.91 $ 2.34 $ 5.22 $ 5.43 Diluted earnings per share $ 1.90 $ 2.33 $ 5.19 $ 5.39 Potentially dilutive securities whose effect would have been antidilutive are excluded from the computation of diluted earnings per share.

Financial Instruments

Financial Instruments	6 Months Ended
	Mar. 26, 2016
Financial Instruments	Note 2 – Financial Instruments Cash, Cash Equivalents and Marketable Securities The following tables show the Company’s cash and available-for-sale March 26, 2016 Adjusted Cost Unrealized Gains Unrealized Losses Fair Value Cash and Cash Equivalents Short-Term Marketable Securities Long-Term Marketable Securities Cash $ 10,199 $ 0 $ 0 $ 10,199 $ 10,199 $ 0 $ 0 Level 1 (1) Money market funds 2,798 0 0 2,798 2,798 0 0 Mutual funds 1,772 0 (203 ) 1,569 0 1,569 0 Subtotal 4,570 0 (203 ) 4,367 2,798 1,569 0 Level 2 (2) U.S. Treasury securities 47,883 207 (24 ) 48,066 3,753 10,614 33,699 U.S. agency securities 6,641 12 (2 ) 6,651 465 2,703 3,483 Non-U.S. government securities 6,873 91 (121 ) 6,843 0 696 6,147 Certificates of deposit and time deposits 4,169 0 0 4,169 1,529 660 1,980 Commercial paper 4,500 0 0 4,500 2,681 1,819 0 Corporate securities 129,394 543 (1,074 ) 128,863 89 15,553 113,221 Municipal securities 952 6 0 958 0 72 886 Mortgage- and asset-backed securities 18,268 86 (42 ) 18,312 0 83 18,229 Subtotal 218,680 945 (1,263 ) 218,362 8,517 32,200 177,645 Total $ 233,449 $ 945 $ (1,466 ) $ 232,928 $ 21,514 $ 33,769 $ 177,645 September 26, 2015 Adjusted Cost Unrealized Gains Unrealized Losses Fair Value Cash and Cash Equivalents Short-Term Marketable Long-Term Marketable Securities Cash $ 11,389 $ 0 $ 0 $ 11,389 $ 11,389 $ 0 $ 0 Level 1 (1) Money market funds 1,798 0 0 1,798 1,798 0 0 Mutual funds 1,772 0 (144 ) 1,628 0 1,628 0 Subtotal 3,570 0 (144 ) 3,426 1,798 1,628 0 Level 2 (2) U.S. Treasury securities 34,902 181 (1 ) 35,082 0 3,498 31,584 U.S. agency securities 5,864 14 0 5,878 841 767 4,270 Non-U.S. government securities 6,356 45 (167 ) 6,234 43 135 6,056 Certificates of deposit and time deposits 4,347 0 0 4,347 2,065 1,405 877 Commercial paper 6,016 0 0 6,016 4,981 1,035 0 Corporate securities 116,908 242 (985 ) 116,165 3 11,948 104,214 Municipal securities 947 5 0 952 0 48 904 Mortgage- and asset-backed securities 16,121 87 (31 ) 16,177 0 17 16,160 Subtotal 191,461 574 (1,184 ) 190,851 7,933 18,853 164,065 Total $ 206,420 $ 574 $ (1,328 ) $ 205,666 $ 21,120 $ 20,481 $ 164,065 (1) The fair value of Level 1 securities is estimated based on quoted prices in active markets for identical assets or liabilities. (2) The fair value of Level 2 securities is estimated based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. The Company may sell certain of its marketable securities prior to their stated maturities for strategic reasons including, but not limited to, anticipation of credit deterioration and duration management. The maturities of the Company’s long-term marketable securities generally range from one to five years. The Company considers the declines in market value of its marketable securities investment portfolio to be temporary in nature. The Company typically invests in highly-rated securities, and its investment policy generally limits the amount of credit exposure to any one issuer. The policy generally requires investments to be investment grade, with the primary objective of minimizing the potential risk of principal loss. Fair values were determined for each individual security in the investment portfolio. When evaluating an investment for other-than-temporary impairment the Company reviews factors such as the length of time and extent to which fair value has been below its cost basis, the financial condition of the issuer and any changes thereto, changes in market interest rates and the Company’s intent to sell, or whether it is more likely than not it will be required to sell the investment before recovery of the investment’s cost basis. As of March 26, 2016, the Company does not consider any of its investments to be other-than-temporarily impaired. Derivative Financial Instruments The Company may use derivatives to partially offset its business exposure to foreign currency and interest rate risk on expected future cash flows, on net investments in certain foreign subsidiaries and on certain existing assets and liabilities. However, the Company may choose not to hedge certain exposures for a variety of reasons including, but not limited to, accounting considerations and the prohibitive economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign currency exchange or interest rates. To help protect gross margins from fluctuations in foreign currency exchange rates, certain of the Company’s subsidiaries whose functional currency is the U.S. dollar may hedge a portion of forecasted foreign currency revenue, and subsidiaries whose functional currency is not the U.S. dollar and who sell in local currencies may hedge a portion of forecasted inventory purchases not denominated in the subsidiaries’ functional currencies. The Company may enter into forward contracts, option contracts or other instruments to manage this risk and may designate these instruments as cash flow hedges. The Company typically hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases, typically for up to 12 months. To help protect the net investment in a foreign operation from adverse changes in foreign currency exchange rates, the Company may enter into foreign currency forward and option contracts to offset the changes in the carrying amounts of these investments due to fluctuations in foreign currency exchange rates. In addition, the Company may use non-derivative financial instruments, such as its foreign currency-denominated debt, as economic hedges of its net investments in certain foreign subsidiaries. In both of these cases, the Company designates these instruments as net investment hedges. The Company may also enter into non-designated foreign currency contracts to partially offset the foreign currency exchange gains and losses generated by the re-measurement of certain assets and liabilities denominated in non-functional currencies. The Company may enter into interest rate swaps, options, or other instruments to manage interest rate risk. These instruments may offset a portion of changes in income or expense, or changes in fair value of the Company’s term debt or investments. The Company designates these instruments as either cash flow or fair value hedges. The Company’s hedged interest rate transactions as of March 26, 2016 are expected to be recognized within ten years. Cash Flow Hedges The effective portions of cash flow hedges are recorded in accumulated other comprehensive income (“AOCI”) until the hedged item is recognized in earnings. Deferred gains and losses associated with cash flow hedges of foreign currency revenue are recognized as a component of net sales in the same period as the related revenue is recognized, and deferred gains and losses related to cash flow hedges of inventory purchases are recognized as a component of cost of sales in the same period as the related costs are recognized. Deferred gains and losses associated with cash flow hedges of interest income or expense are recognized in other income/(expense), net in the same period as the related income or expense is recognized. The ineffective portions and amounts excluded from the effectiveness testing of cash flow hedges are recognized in other income/(expense), net. Derivative instruments designated as cash flow hedges must be de-designated as hedges when it is probable the forecasted hedged transaction will not occur in the initially identified time period or within a subsequent two-month time period. Deferred gains and losses in AOCI associated with such derivative instruments are reclassified immediately into other income/(expense), net. Any subsequent changes in fair value of such derivative instruments are reflected in other income/(expense), net unless they are re-designated as hedges of other transactions. Net Investment Hedges The effective portions of net investment hedges are recorded in other comprehensive income (“OCI”) as a part of the cumulative translation adjustment. The ineffective portions and amounts excluded from the effectiveness testing of net investment hedges are recognized in other income/(expense), net. Fair Value Hedges Gains and losses related to changes in fair value hedges are recognized in earnings along with a corresponding loss or gain related to the change in value of the underlying hedged item. Non-Designated Derivatives Derivatives that are not designated as hedging instruments are adjusted to fair value through earnings in the financial statement line item to which the derivative relates. The Company records all derivatives in the Condensed Consolidated Balance Sheets at fair value. The Company’s accounting treatment for these derivative instruments is based on its hedge designation. The following tables show the Company’s derivative instruments at gross fair value as of March 26, 2016 and September 26, 2015 (in millions): March 26, 2016 Fair Value of Derivatives Designated as Hedge Instruments Fair Value of Derivatives Not Designated as Hedge Instruments Total Fair Value Derivative assets (1) Foreign exchange contracts $ 564 $ 69 $ 633 Interest rate contracts $ 557 $ 0 $ 557 Derivative liabilities (2) Foreign exchange contracts $ 1,033 $ 243 $ 1,276 Interest rate contracts $ 36 $ 0 $ 36 September 26, 2015 Fair Value of as Hedge Instruments Fair Value of Derivatives Not Designated Total Fair Value Derivative assets (1) Foreign exchange contracts $ 1,442 $ 109 $ 1,551 Interest rate contracts $ 394 $ 0 $ 394 Derivative liabilities (2) Foreign exchange contracts $ 905 $ 94 $ 999 Interest rate contracts $ 13 $ 0 $ 13 (1) The fair value of derivative assets is measured using Level 2 fair value inputs and is recorded as other current assets in the Condensed Consolidated Balance Sheets. (2) The fair value of derivative liabilities is measured using Level 2 fair value inputs and is recorded as accrued expenses in the Condensed Consolidated Balance Sheets. The following table shows the pre-tax gains and losses of the Company’s derivative and non-derivative instruments designated as cash flow, net investment and fair value hedges on OCI and the Condensed Consolidated Statements of Operations for the three- and six-month periods ended March 26, 2016 and March 28, 2015 (in millions): Three Months Ended Six Months Ended March 26, 2016 March 28, 2015 March 26, 2016 March 28, 2015 Gains/(Losses) recognized in OCI – effective portion: Cash flow hedges: Foreign exchange contracts $ (138 ) $ 1,249 $ 188 $ 3,750 Interest rate contracts (50 ) (87 ) (42 ) (91 ) Total $ (188 ) $ 1,162 $ 146 $ 3,659 Net investment hedges: Foreign exchange contracts $ 0 $ (6 ) $ 0 $ 112 Foreign currency debt (87 ) 0 (77 ) 0 Total $ (87 ) $ (6 ) $ (77 ) $ 112 Gains/(Losses) reclassified from AOCI into net income – effective portion: Cash flow hedges: Foreign exchange contracts $ 668 $ 818 $ 1,183 $ 1,485 Interest rate contracts (3 ) (5 ) (7 ) (9 ) Total $ 665 $ 813 $ 1,176 $ 1,476 Gains/(Losses) on derivative instruments: Fair value hedges: Interest rate contracts $ 250 $ 122 $ 139 $ 239 Gains/(Losses) related to hedged items: Fair value hedges: Interest rate contracts $ (250 ) $ (122 ) $ (139 ) $ (239 ) The following table shows the notional amounts of the Company’s outstanding derivative instruments and credit risk amounts associated with outstanding or unsettled derivative instruments as of March 26, 2016 and September 26, 2015 (in millions): March 26, 2016 September 26, 2015 Notional Credit Risk Notional Credit Risk Instruments designated as accounting hedges: Foreign exchange contracts $ 41,996 $ 564 $ 70,054 $ 1,385 Interest rate contracts $ 23,750 $ 557 $ 18,750 $ 394 Instruments not designated as accounting hedges: Foreign exchange contracts $ 30,573 $ 69 $ 49,190 $ 109 The notional amounts for outstanding derivative instruments provide one measure of the transaction volume outstanding and do not represent the amount of the Company’s exposure to credit or market loss. The credit risk amounts represent the Company’s gross exposure to potential accounting loss on derivative instruments that are outstanding or unsettled if all counterparties failed to perform according to the terms of the contract, based on then-current The Company generally enters into master netting arrangements, which are designed to reduce credit risk by permitting net settlement of transactions with the same counterparty. To further limit credit risk, the Company generally enters into collateral security arrangements that provide for collateral to be received or posted when the net fair value of certain financial instruments fluctuates from contractually established thresholds. The Company presents its derivative assets and derivative liabilities at their gross fair values in its Condensed Consolidated Balance Sheets. As of March 26, 2016, the net cash collateral posted by the Company related to derivative instruments under its collateral security arrangements was $3 million, which was recorded as other current assets in the Condensed Consolidated Balance Sheet. As of September 26, 2015, the net cash collateral received by the Company related to derivative instruments under its collateral security arrangements was $1.0 billion, which was recorded as accrued expenses in the Condensed Consolidated Balance Sheet. Under master netting arrangements with the respective counterparties to the Company’s derivative contracts, the Company is allowed to net settle transactions with a single net amount payable by one party to the other. As of March 26, 2016 and September 26, 2015, the potential effects of these rights of set-off associated with the Company’s derivative contracts, including the effects of collateral, would be a reduction to both derivative assets and derivative liabilities of $1.4 billion and $2.2 billion, respectively, resulting in net derivative liabilities of $119 million and $78 million, respectively. Accounts Receivable Trade Receivables The Company has considerable trade receivables outstanding with its third-party cellular network carriers, wholesalers, retailers, value-added resellers, small and mid-sized businesses and education, enterprise and government customers that are not covered by collateral, third-party financing arrangements or credit insurance. As of March 26, 2016 and September 26, 2015, the Company had one customer that represented 12% of total trade receivables. The Company’s cellular network carriers accounted for 55% and 71% of trade receivables as of March 26, 2016 and September 26, 2015, respectively. Vendor Non-Trade Receivables The Company has non-trade receivables from certain of its manufacturing vendors resulting from the sale of components to these vendors who manufacture sub-assemblies or assemble final products for the Company. Vendor non-trade receivables from three of the Company’s vendors accounted for 55%, 14% and 11% of total vendor non-trade receivables as of March 26, 2016 and three of the Company’s vendors accounted for 38%, 18% and 14% of total vendor non-trade receivables as of September 26, 2015.

Condensed Consolidated Financia

Condensed Consolidated Financial Statement Details	6 Months Ended
	Mar. 26, 2016
Condensed Consolidated Financial Statement Details	Note 3 – Condensed Consolidated Financial Statement Details The following tables show the Company’s condensed consolidated financial statement details as of March 26, 2016 and September 26, 2015 (in millions): Property, Plant and Equipment, Net March 26, 2016 September 26, 2015 Land and buildings $ 8,391 $ 6,956 Machinery, equipment and internal-use software 39,723 37,038 Leasehold improvements 5,937 5,263 Gross property, plant and equipment 54,051 49,257 Accumulated depreciation and amortization (30,848 ) (26,786 ) Total property, plant and equipment, net $ 23,203 $ 22,471 Other Non-Current Liabilities March 26, 2016 September 26, 2015 Deferred tax liabilities $ 22,955 $ 24,062 Other non-current liabilities 10,904 9,365 Total other non-current liabilities $ 33,859 $ 33,427 Other Income/(Expense), Net The following table shows the detail of other income/(expense), net for the three- and six-month periods ended March 26, 2016 and March 28, 2015 (in millions): Three Months Ended Six Months Ended March 26, 2016 March 28, 2015 March 26, 2016 March 28, 2015 Interest and dividend income $ 986 $ 675 $ 1,927 $ 1,329 Interest expense (321 ) (163 ) (597 ) (294 ) Other expense, net (510 ) (226 ) (773 ) (579 ) Total other income/(expense), net $ 155 $ 286 $ 557 $ 456

Acquired Intangible Assets

Acquired Intangible Assets	6 Months Ended
	Mar. 26, 2016
Acquired Intangible Assets	Note 4 – Acquired Intangible Assets The Company’s acquired intangible assets with definite useful lives primarily consist of patents and licenses and are amortized over periods typically from three to seven years. The following table summarizes the components of gross and net acquired intangible asset balances as of March 26, 2016 and September 26, 2015 (in millions): March 26, 2016 September 26, 2015 Gross Accumulated Net Gross Accumulated Net Definite-lived and amortizable acquired intangible assets $ 8,797 $ (5,054 ) $ 3,743 $ 8,125 $ (4,332 ) $ 3,793 Indefinite-lived and non-amortizable acquired intangible assets 100 0 100 100 0 100 Total acquired intangible assets $ 8,897 $ (5,054 ) $ 3,843 $ 8,225 $ (4,332 ) $ 3,893

Income Taxes

Income Taxes	6 Months Ended
	Mar. 26, 2016
Income Taxes	Note 5 – Income Taxes As of March 26, 2016, the Company recorded gross unrecognized tax benefits of $7.5 billion, of which $2.8 billion, if recognized, would affect the Company’s effective tax rate. As of September 26, 2015, the total amount of gross unrecognized tax benefits was $6.9 billion, of which $2.5 billion, if recognized, would have affected the Company’s effective tax rate. The Company’s total gross unrecognized tax benefits are classified as other non-current liabilities in the Condensed Consolidated Balance Sheets. The Company had $1.5 billion and $1.3 billion of gross interest and penalties accrued as of March 26, 2016 and September 26, 2015, respectively, which are classified as other non-current liabilities in the Condensed Consolidated Balance Sheets. Management believes that an adequate provision has been made for any adjustments that may result from tax examinations. However, the outcome of tax audits cannot be predicted with certainty. If any issues addressed in the Company’s tax audits are resolved in a manner not consistent with management’s expectations, the Company could be required to adjust its provision for income taxes in the period such resolution occurs. Although timing of the resolution and/or closure of audits is not certain, the Company believes it is reasonably possible that its gross unrecognized tax benefits could decrease (whether by payment, release or a combination of both) in the next 12 months by as much as $800 million. On June 11, 2014, the European Commission issued an opening decision initiating a formal investigation against Ireland for alleged state aid to the Company. The opening decision concerns the allocation of profits for taxation purposes of the Irish branches of two subsidiaries of the Company. The Company believes the European Commission’s assertions are without merit. If the European Commission were to conclude against Ireland, the European Commission could require Ireland to recover from the Company past taxes covering a period of up to 10 years reflective of the disallowed state aid. While such amount could be material, as of March 26, 2016 the Company is unable to estimate the impact.

Debt

Debt	6 Months Ended
	Mar. 26, 2016
Debt	Note 6 – Debt Commercial Paper The Company issues unsecured short-term promissory notes (“Commercial Paper”) pursuant to a commercial paper program. The Company uses net proceeds from the commercial paper program for general corporate purposes, including dividends and share repurchases. As of March 26, 2016 and September 26, 2015, the Company had $8.0 billion and $8.5 billion of Commercial Paper outstanding, respectively, with maturities generally less than nine months. The weighted-average interest rate of the Company’s Commercial Paper was 0.39% as of March 26, 2016 and 0.14% as of September 26, 2015. The following table provides a summary of cash flows associated with the issuance and maturities of Commercial Paper for the six months ended March 26, 2016 and March 28, 2015 (in millions): Six Months Ended March 26, 2016 March 28, 2015 Maturities less than 90 days: Proceeds from (repayments of) commercial paper, net $ 660 $ 985 Maturities greater than 90 days: Proceeds from commercial paper 669 547 Repayments of commercial paper (1,832 ) (4,040 ) Proceeds from (repayments of) commercial paper, net (1,163 ) (3,493 ) Total change in commercial paper, net $ (503 ) $ (2,508 ) Long-Term Debt As of March 26, 2016, the Company had outstanding floating- and fixed-rate notes with varying maturities for an aggregate principal amount of $71.3 billion (collectively the “Notes”). The Notes are senior unsecured obligations, and interest is payable in arrears, quarterly for the U.S. dollar-denominated and Australian dollar-denominated floating-rate notes, semi-annually for the U.S. dollar-denominated, Australian dollar-denominated, British pound-denominated and Japanese yen-denominated fixed-rate notes and annually for the euro-denominated and Swiss franc-denominated fixed-rate notes. The following table provides a summary of the Company’s term debt as of March 26, 2016 and September 26, 2015: March, 26, 2016 September 26, 2015 Maturities Amount Effective Interest Rate Amount Effective Interest Rate 2013 debt issuance of $17.0 billion: Floating-rate notes 2016 - 2018 $ 3,000 0.51% - 1.10% $ 3,000 0.51% - 1.10% Fixed-rate 0.45% - 3.85% notes 2016 - 2043 14,000 0.51% - 3.91% 14,000 0.51% - 3.91% 2014 debt issuance of $12.0 billion: Floating-rate notes 2017 - 2019 2,000 0.69% - 0.92% 2,000 0.37% - 0.60% Fixed-rate 1.05% - 4.45% notes 2017 - 2044 10,000 0.69% - 4.48% 10,000 0.37% - 4.48% 2015 debt issuances of $27.3 billion: Floating-rate notes 2017 - 2020 1,781 0.67% - 1.87% 1,743 0.36% - 1.87% Fixed-rate 0.35% - 4.375% notes 2017 - 2045 25,063 0.28% - 4.51% 24,958 0.28% - 4.51% Second quarter 2016 debt issuance of $15.5 billion: Floating-rate notes 2019 500 1.44% 0 0 Floating-rate notes 2021 500 1.75% 0 0 Fixed-rate 1.30% notes 2018 500 1.32% 0 0 Fixed-rate 1.70% notes 2019 1,000 1.71% 0 0 Fixed-rate 2.25% notes 2021 3,000 1.80% 0 0 Fixed-rate 2.85% notes 2023 1,500 2.48% 0 0 Fixed-rate 3.25% notes 2026 3,250 2.33% 0 0 Fixed-rate 4.50% notes 2036 1,250 4.54% 0 0 Fixed-rate 4.65% notes 2046 4,000 4.58% 0 0 Total debt issuance 15,500 0 Total term debt 71,344 55,701 Unamortized premium/(discount) 15 (114 ) Hedge accounting fair value adjustments 515 376 Less: Current portion of long-term debt (2,500 ) (2,500 ) Total long-term debt $ 69,374 $ 53,463 During the second quarter of 2016, the Company issued $15.5 billion U.S. dollar-denominated notes. To manage interest rate risk on the U.S. dollar-denominated fixed-rate notes maturing in 2021, 2023 and 2026, the Company entered into interest rate swaps with an aggregate notional amount of $5.0 billion, which effectively converted a portion of the fixed interest rates on these notes to a floating interest rate. As of March 26, 2016, ¥149.3 billion of Japanese yen-denominated notes was designated as a hedge of the foreign currency exposure of its net investment in a foreign operation. The foreign currency transaction gain or loss on the Japanese yen-denominated debt designated as a hedge is recorded in OCI as a part of the cumulative translation adjustment. As of March 26, 2016 and September 26, 2015, the carrying value of the debt designated as a net investment hedge was $1.3 billion and $2.1 billion, respectively. For further discussion regarding the Company’s use of derivative instruments see the Derivative Financial Instruments section of Note 2, “Financial Instruments.” The effective interest rates for the Notes include the interest on the Notes, amortization of the discount and, if applicable, adjustments related to hedging. The Company recognized $311 million and $582 million of interest expense on its term debt for the three- and six-month periods ended March 26, 2016, respectively. The Company recognized $161 million and $289 million of interest expense on its term debt for the three- and six-month periods ended March 28, 2015, respectively. As of March 26, 2016 and September 26, 2015, the fair value of the Company’s Notes, based on Level 2 inputs, was $72.4 billion and $54.9 billion, respectively.

Shareholders' Equity

Shareholders' Equity	6 Months Ended
	Mar. 26, 2016
Shareholders' Equity	Note 7 – Shareholders’ Equity Dividends The Company declared and paid cash dividends per share during the periods presented as follows: Dividends Per Share Amount 2016: Second quarter $ 0.52 $ 2,879 First quarter 0.52 2,898 Total cash dividends declared and paid $ 1.04 $ 5,777 2015: Fourth quarter $ 0.52 $ 2,950 Third quarter 0.52 2,997 Second quarter 0.47 2,734 First quarter 0.47 2,750 Total cash dividends declared and paid $ 1.98 $ 11,431 Future dividends are subject to declaration by the Board of Directors. Share Repurchase Program In 2015, the Company’s Board of Directors increased the share repurchase authorization to $140 billion of the Company’s common stock, of which $117 billion had been utilized as of March 26, 2016. The Company’s share repurchase program does not obligate it to acquire any specific number of shares. Under the program, shares may be repurchased in privately negotiated and/or open market transactions, including under plans complying with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The Company has entered, and in the future may enter, into accelerated share repurchase arrangements (“ASRs”) with financial institutions. In exchange for up-front payments, the financial institutions deliver shares of the Company’s common stock during the purchase periods of each ASR. The total number of shares ultimately delivered, and therefore the average repurchase price paid per share, is determined at the end of the applicable purchase period of each ASR based on the volume weighted-average price of the Company’s common stock during that period. The shares received are retired in the periods they are delivered, and the up-front payments are accounted for as a reduction to shareholders’ equity in the Company’s Condensed Consolidated Balance Sheets in the periods the payments are made. The Company reflects the ASRs as a repurchase of common stock in the period delivered for purposes of calculating earnings per share and as forward contracts indexed to its own common stock. The ASRs met all of the applicable criteria for equity classification, and therefore were not accounted for as derivative instruments. The following table shows the Company’s ASR activity and related information during the six months ended March 26, 2016 and the year ended September 26, 2015: Purchase Period Number of Shares Average ASR Amount November 2015 ASR April 2016 20,382 (1) $ (1) $ 3,000 May 2015 ASR July 2015 48,293 $ 124.24 $ 6,000 August 2014 ASR February 2015 81,525 $ 110.40 $ 9,000 January 2014 ASR December 2014 134,247 $ 89.39 $ 12,000 (1) “Number of Shares” represents those shares delivered in the beginning of the purchase period and does not represent the final number of shares to be delivered under the ASR. The total number of shares ultimately delivered, and therefore the average repurchase price paid per share, will be determined at the end of the applicable purchase period based on the volume-weighted average price of the Company’s common stock during that period. The November 2015 ASR purchase period will end in or before April 2016. Additionally, the Company repurchased shares of its common stock in the open market, which were retired upon repurchase, during the periods presented as follows: Number of Shares Average Repurchase Amount 2016: Second quarter 71,766 $ 97.54 $ 7,000 First quarter 25,984 $ 115.45 3,000 Total open market common stock repurchases 97,750 $ 10,000 2015: Fourth quarter 121,802 $ 115.15 $ 14,026 Third quarter 31,231 $ 128.08 4,000 Second quarter 56,400 $ 124.11 7,000 First quarter 45,704 $ 109.40 5,000 Total open market common stock repurchases 255,137 $ 30,026

Comprehensive Income

Comprehensive Income	6 Months Ended
	Mar. 26, 2016
Comprehensive Income	Note 8 – Comprehensive Income Comprehensive income consists of two components, net income and OCI. OCI refers to revenue, expenses, and gains and losses that under GAAP are recorded as an element of shareholders’ equity but are excluded from net income. The Company’s OCI consists of foreign currency translation adjustments from those subsidiaries not using the U.S. dollar as their functional currency, net deferred gains and losses on certain derivative instruments accounted for as cash flow hedges and unrealized gains and losses on marketable securities classified as available-for-sale. The following table shows the pre-tax amounts reclassified from AOCI into the Condensed Consolidated Statements of Operations, and the associated financial statement line item, for the three- and six-month periods ended March 26, 2016 and March 28, 2015 (in millions): Three Months Ended Six Months Ended Comprehensive Income Components Financial Statement Line Item March 26, 2016 March 28, March 26, 2016 March 28, Unrealized (gains)/losses on derivative instruments: Foreign exchange contracts Revenue $ (325 ) $ (558 ) $ (654 ) $ (1,007 ) Cost of sales (219 ) (608 ) (525 ) (921 ) Other income/(expense), net (131 ) 348 (11 ) 443 Interest rate contracts Other income/(expense), net 3 4 7 8 (672 ) (814 ) (1,183 ) (1,477 ) Unrealized (gains)/losses on marketable securities Other income/(expense), net 76 56 149 34 Total amounts reclassified from AOCI $ (596 ) $ (758 ) $ (1,034 ) $ (1,443 ) The following table shows the changes in AOCI by component for the six months ended March 26, 2016 (in millions): Cumulative Unrealized Unrealized Total Balance at September 26, 2015 $ (653 ) $ 772 $ (464 ) $ (345 ) Other comprehensive income/(loss) before reclassifications 18 146 69 233 Amounts reclassified from AOCI 0 (1,183 ) 149 (1,034 ) Tax effect 0 173 (75 ) 98 Other comprehensive income/(loss) 18 (864 ) 143 (703 ) Balance at March 26, 2016 $ (635 ) $ (92 ) $ (321 ) $ (1,048 )

Benefit Plans

Benefit Plans	6 Months Ended
	Mar. 26, 2016
Benefit Plans	Note 9 – Benefit Plans Stock Plans The Company had 377.3 million shares reserved for future issuance under its stock plans as of March 26, 2016. RSUs granted generally vest over four years, based on continued employment, and are settled upon vesting in shares of the Company’s common stock on a one-for-one basis. Each share issued with respect to RSUs granted under the Company’s stock plans reduces the number of shares available for grant under the plan by two shares. RSUs cancelled and shares withheld to satisfy tax withholding obligations increase the number of shares available for grant under the plans utilizing a factor of two times the number of RSUs cancelled or shares withheld. Stock options count against the number of shares available for grant on a one-for-one basis. Rule 10b5-1 Trading Plans During the three months ended March 26, 2016, Section 16 officers Timothy D. Cook, Angela Ahrendts, Luca Maestri, Daniel Riccio, Philip Schiller and Jeffrey Williams had equity trading plans in place in accordance with Rule 10b5-1(c)(1) under the Exchange Act. An equity trading plan is a written document that pre-establishes the amounts, prices and dates (or formula for determining the amounts, prices and dates) of future purchases or sales of the Company’s stock, including shares acquired pursuant to the Company’s employee and director equity plans. Restricted Stock Units A summary of the Company’s RSU activity and related information for the six months ended March 26, 2016 is as follows: Number of Weighted-Average Grant Date Fair Aggregate Balance at September 26, 2015 101,467 $ 85.77 RSUs granted 43,513 $ 110.57 RSUs vested (22,353 ) $ 78.86 RSUs cancelled (2,413 ) $ 93.43 Balance at March 26, 2016 120,214 $ 95.80 $ 12,703 RSUs that vested during the three- and six-month periods ended March 26, 2016 had fair values of $450 million and $2.5 billion, respectively, as of the vesting date. RSUs that vested during the three- and six-month periods ended March 28, 2015 had fair values of $317 million and $2.0 billion, respectively, as of the vesting date. Stock Options The Company had 1.1 million stock options outstanding as of March 26, 2016, with a weighted-average exercise price per share of $15.48 and weighted-average remaining contractual term of 3.7 years, substantially all of which are exercisable. The aggregate intrinsic value of the stock options outstanding as of March 26, 2016 was $100 million, which represents the value of the Company’s closing stock price on the last trading day of the period in excess of the weighted-average exercise price multiplied by the number of options outstanding. Share-Based Compensation The following table shows a summary of the share-based compensation expense included in the Condensed Consolidated Statements of Operations for the three- and six-month periods ended March 26, 2016 and March 28, 2015 (in millions): Three Months Ended Six Months Ended March 26, March 28, March 26, March 28, Cost of sales $ 191 $ 142 $ 395 $ 282 Research and development 468 384 934 758 Selling, general and administrative 389 401 797 775 Total share-based compensation expense $ 1,048 $ 927 $ 2,126 $ 1,815 The income tax benefit related to share-based compensation expense was $347 million and $760 million for the three- and six-month periods ended March 26, 2016, respectively, and was $311 million and $662 million for the three- and six-month periods ended March 28, 2015, respectively. As of March 26, 2016, the total unrecognized compensation cost related to outstanding stock options, RSUs and restricted stock was $9.1 billion, which the Company expects to recognize over a weighted-average period of 2.9 years.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Mar. 26, 2016
Commitments and Contingencies	Note 10 – Commitments and Contingencies Accrued Warranty and Indemnification The following table shows changes in the Company’s accrued warranties and related costs for the three- and six-month periods ended March 26, 2016 and March 28, 2015 (in millions): Three Months Ended Six Months Ended March 26, March 28, March 26, March 28, Beginning accrued warranty and related costs $ 5,236 $ 5,195 $ 4,780 $ 4,159 Cost of warranty claims (1,128 ) (1,030 ) (2,397 ) (2,074 ) Accruals for product warranty 877 978 2,602 3,058 Ending accrued warranty and related costs $ 4,985 $ 5,143 $ 4,985 $ 5,143 The Company generally does not indemnify end-users of its operating system and application software against legal claims that the software infringes third-party intellectual property rights. Other agreements entered into by the Company sometimes include indemnification provisions under which the Company could be subject to costs and/or damages in the event of an infringement claim against the Company or an indemnified third-party. In the opinion of management, there was not at least a reasonable possibility the Company may have incurred a material loss with respect to indemnification of end-users of its operating system or application software for infringement of third-party intellectual property rights. The Company offers an iPhone Upgrade Program, which is available to customers who purchase an iPhone 6s and 6s Plus in one of its U.S. physical retail stores and activate the purchased iPhone with one of the four national carriers. The iPhone Upgrade Program provides customers the right to trade in that iPhone for a new iPhone, provided certain conditions are met. One of the conditions of this program requires the customer to finance the initial purchase price of the iPhone with a third-party lender. Upon exercise of the trade-in right and purchase of a new iPhone, the Company satisfies the customer’s outstanding balance due to the third-party lender on the original device. The Company accounts for the trade-in right as a guarantee liability and recognizes arrangement revenue net of the fair value of such right with subsequent changes to the guarantee liability recognized within revenue. The Company has entered into indemnification agreements with its directors and executive officers. Under these agreements, the Company has agreed to indemnify such individuals to the fullest extent permitted by law against liabilities that arise by reason of their status as directors or officers and to advance expenses incurred by such individuals in connection with related legal proceedings. It is not possible to determine the maximum potential amount of payments the Company could be required to make under these agreements due to the limited history of prior indemnification claims and the unique facts and circumstances involved in each claim. However, the Company maintains directors and officers liability insurance coverage to reduce its exposure to such obligations. Concentrations in the Available Sources of Supply of Materials and Product Although most components essential to the Company’s business are generally available from multiple sources, a number of components are currently obtained from single or limited sources. In addition, the Company competes for various components with other participants in the markets for mobile communication and media devices and personal computers. Therefore, many components used by the Company, including those that are available from multiple sources, are at times subject to industry-wide shortage and significant pricing fluctuations that could materially adversely affect the Company’s financial condition and operating results. The Company uses some custom components that are not commonly used by its competitors, and new products introduced by the Company often utilize custom components available from only one source. When a component or product uses new technologies, initial capacity constraints may exist until the suppliers’ yields have matured or manufacturing capacity has increased. If the Company’s supply of components for a new or existing product were delayed or constrained, or if an outsourcing partner delayed shipments of completed products to the Company, the Company’s financial condition and operating results could be materially adversely affected. The Company’s business and financial performance could also be materially adversely affected depending on the time required to obtain sufficient quantities from the original source, or to identify and obtain sufficient quantities from an alternative source. Continued availability of these components at acceptable prices, or at all, may be affected if those suppliers concentrated on the production of common components instead of components customized to meet the Company’s requirements. The Company has entered into agreements for the supply of many components; however, there can be no guarantee that the Company will be able to extend or renew these agreements on similar terms, or at all. Therefore, the Company remains subject to significant risks of supply shortages and price increases that could materially adversely affect its financial condition and operating results. Substantially all of the Company’s hardware products are manufactured by outsourcing partners that are located primarily in Asia. A significant concentration of this manufacturing is currently performed by a small number of outsourcing partners, often in single locations. Certain of these outsourcing partners are the sole-sourced suppliers of components and manufacturers for many of the Company’s products. Although the Company works closely with its outsourcing partners on manufacturing schedules, the Company’s operating results could be adversely affected if its outsourcing partners were unable to meet their production commitments. The Company’s purchase commitments typically cover its requirements for periods up to 150 days. Other Off-Balance Sheet Commitments Operating Leases The Company leases various equipment and facilities, including retail space, under noncancelable operating lease arrangements. The major facility leases are typically for terms not exceeding 10 years and generally contain multi-year renewal options. As of March 26, 2016, the Company had a total of 475 retail stores. Leases for retail space are for terms ranging from five to 20 years, the majority of which are for 10 years, and often contain multi-year renewal options. As of March 26, 2016, the Company’s total future minimum lease payments under noncancelable operating leases were $6.8 billion, of which $3.9 billion related to leases for retail space. Contingencies The Company is subject to various legal proceedings and claims that have arisen in the ordinary course of business and that have not been fully adjudicated, certain of which are discussed in Part II, Item 1 of this Form 10-Q under the heading “Legal Proceedings” and in Part II, Item 1A of this Form 10-Q under the heading “Risk Factors.” In the opinion of management, there was not at least a reasonable possibility the Company may have incurred a material loss, or a material loss in excess of a recorded accrual, with respect to loss contingencies for asserted legal and other claims. However, the outcome of litigation is inherently uncertain. Therefore, although management considers the likelihood of such an outcome to be remote, if one or more of these legal matters were resolved against the Company in a reporting period for amounts in excess of management’s expectations, the Company’s consolidated financial statements for that reporting period could be materially adversely affected. Apple Inc. v. Samsung Electronics Co., Ltd., et al. On August 24, 2012, a jury returned a verdict awarding the Company $1.05 billion in its lawsuit against Samsung Electronics Co., Ltd. and affiliated parties in the United States District Court, Northern District of California, San Jose Division. On March 6, 2014, the District Court entered final judgment in favor of the Company in the amount of approximately $930 million. On May 18, 2015, the U.S. Court of Appeals for the Federal Circuit affirmed in part, and reversed in part, the decision of the District Court. As a result, the Court of Appeals ordered entry of final judgment on damages in the amount of approximately $548 million, with the District Court to determine supplemental damages and interest, as well as damages owed for products subject to the reversal in part. Samsung paid $548 million to the Company in December 2015, which was included in net sales in the Condensed Consolidated Statement of Operations. Because the case remains subject to further proceedings, the Company has not recognized any further amounts in its results of operations. On March 21, 2016, the United States Supreme Court agreed to hear Samsung’s request for appeal related to the $548 million in damages.

Segment Information and Geograp

Segment Information and Geographic Data	6 Months Ended
	Mar. 26, 2016
Segment Information and Geographic Data	Note 11 – Segment Information and Geographic Data The Company reports segment information based on the “management” approach. The management approach designates the internal reporting used by management for making decisions and assessing performance as the source of the Company’s reportable operating segments. The Company manages its business primarily on a geographic basis. The Company’s reportable operating segments consist of the Americas, Europe, Greater China, Japan and Rest of Asia Pacific. The Americas segment includes both North and South America. The Europe segment includes European countries, as well as India, the Middle East and Africa. The Greater China segment includes China, Hong Kong and Taiwan. The Rest of Asia Pacific segment includes Australia and those Asian countries not included in the Company’s other reportable operating segments. Although the reportable operating segments provide similar hardware and software products and similar services, each one is managed separately to better align with the location of the Company’s customers and distribution partners and the unique market dynamics of each geographic region. The accounting policies of the various segments are the same as those described in Note 1, “Summary of Significant Accounting Policies” of the Notes to Consolidated Financial Statements in Part II, Item 8 of the 2015 Form 10-K. The Company evaluates the performance of its reportable operating segments based on net sales and operating income. Net sales for geographic segments are generally based on the location of customers and sales through the Company’s retail stores located in those geographic locations. Operating income for each segment includes net sales to third parties, related cost of sales and operating expenses directly attributable to the segment. Advertising expenses are generally included in the geographic segment in which the expenditures are incurred. Operating income for each segment excludes other income and expense and certain expenses managed outside the reportable operating segments. Costs excluded from segment operating income include various corporate expenses such as research and development, corporate marketing expenses, certain share-based compensation expenses, income taxes, various nonrecurring charges and other separately managed general and administrative costs. The Company does not include intercompany transfers between segments for management reporting purposes. The following table shows information by reportable operating segment for the three- and six-month periods ended March 26, 2016 and March 28, 2015 (in millions): Three Months Ended Six Months Ended March 26, 2016 March 28, 2015 March 26, 2016 March 28, 2015 Americas: Net sales $ 19,096 $ 21,316 $ 48,421 $ 51,882 Operating income $ 6,116 $ 7,186 $ 16,134 $ 17,887 Europe: Net sales $ 11,535 $ 12,204 $ 29,467 $ 29,418 Operating income $ 3,602 $ 4,112 $ 9,381 $ 9,994 Greater China: Net sales $ 12,486 $ 16,823 $ 30,859 $ 32,967 Operating income $ 4,818 $ 6,714 $ 12,394 $ 13,080 Japan: Net sales $ 4,281 $ 3,457 $ 9,075 $ 8,905 Operating income $ 1,930 $ 1,699 $ 4,170 $ 4,187 Rest of Asia Pacific: Net sales $ 3,159 $ 4,210 $ 8,607 $ 9,437 Operating income $ 1,095 $ 1,600 $ 3,127 $ 3,449 A reconciliation of the Company’s segment operating income to the Condensed Consolidated Statements of Operations for the three- and six-month periods ended March 26, 2016 and March 28, 2015 (in millions): Three Months Ended Six Months Ended March 26, 2016 March 28, 2015 March 26, 2016 March 28, 2015 Segment operating income $ 17,561 $ 21,311 $ 45,206 $ 48,597 Research and development expense (2,511 ) (1,918 ) (4,915 ) (3,813 ) Other corporate expenses, net (1,063 ) (1,115 ) (2,133 ) (2,260 ) Total operating income $ 13,987 $ 18,278 $ 38,158 $ 42,524

Summary of Significant Accoun18

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Mar. 26, 2016
Basis of Presentation and Preparation	Basis of Presentation and Preparation The accompanying condensed consolidated financial statements include the accounts of the Company. Intercompany accounts and transactions have been eliminated. In the opinion of the Company’s management, the condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. The preparation of these condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the amounts reported in these condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. Certain prior period amounts in the condensed consolidated financial statements have been reclassified to conform to the current period’s presentation. These condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company’s annual consolidated financial statements and the notes thereto included in its Annual Report on Form 10-K for the fiscal year ended September 26, 2015 (the “2015 Form 10-K”). The Company’s fiscal year is the 52 or 53-week period that ends on the last Saturday of September. An additional week is included in the first fiscal quarter approximately every six years to realign fiscal quarters with calendar quarters. The Company’s fiscal years 2016 and 2015 each include 52 weeks. Unless otherwise stated, references to particular years, quarters or months refer to the Company’s fiscal years ended in September and the associated quarters or months of those fiscal years. During the first quarter of 2016, the Company adopted an accounting standard that simplified the presentation of deferred taxes by requiring deferred tax assets and liabilities be classified as noncurrent in a classified statement of financial position. The Company has adopted this accounting standard prospectively; accordingly, the prior period amounts in the Company’s Condensed Consolidated Balance Sheets within this Quarterly Report on Form 10-Q were not adjusted to conform to the new accounting standard. The adoption of this accounting standard was not material to the Company’s condensed consolidated financial statements.
Earnings Per Share	Earnings Per Share Basic earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding stock options, shares to be purchased under the Company’s employee stock purchase plan, unvested restricted stock and unvested restricted stock units (“RSUs”). The dilutive effect of potentially dilutive securities is reflected in diluted earnings per share by application of the treasury stock method. Under the treasury stock method, an increase in the fair market value of the Company’s common stock can result in a greater dilutive effect from potentially dilutive securities. The following table shows the computation of basic and diluted earnings per share for the three- and six-month periods ended March 26, 2016 and March 28, 2015 (net income in millions and shares in thousands): Three Months Ended Six Months Ended March 26, 2016 March 28, 2015 March 26, 2016 March 28, 2015 Numerator: Net income $ 10,516 $ 13,569 $ 28,877 $ 31,593 Denominator: Weighted-average shares outstanding 5,514,381 5,793,799 5,536,656 5,818,441 Effect of dilutive securities 26,505 41,059 30,850 39,889 Weighted-average diluted shares 5,540,886 5,834,858 5,567,506 5,858,330 Basic earnings per share $ 1.91 $ 2.34 $ 5.22 $ 5.43 Diluted earnings per share $ 1.90 $ 2.33 $ 5.19 $ 5.39 Potentially dilutive securities whose effect would have been antidilutive are excluded from the computation of diluted earnings per share.
Derivative Financial Instruments	Derivative Financial Instruments The Company may use derivatives to partially offset its business exposure to foreign currency and interest rate risk on expected future cash flows, on net investments in certain foreign subsidiaries and on certain existing assets and liabilities. However, the Company may choose not to hedge certain exposures for a variety of reasons including, but not limited to, accounting considerations and the prohibitive economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign currency exchange or interest rates. To help protect gross margins from fluctuations in foreign currency exchange rates, certain of the Company’s subsidiaries whose functional currency is the U.S. dollar may hedge a portion of forecasted foreign currency revenue, and subsidiaries whose functional currency is not the U.S. dollar and who sell in local currencies may hedge a portion of forecasted inventory purchases not denominated in the subsidiaries’ functional currencies. The Company may enter into forward contracts, option contracts or other instruments to manage this risk and may designate these instruments as cash flow hedges. The Company typically hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases, typically for up to 12 months. To help protect the net investment in a foreign operation from adverse changes in foreign currency exchange rates, the Company may enter into foreign currency forward and option contracts to offset the changes in the carrying amounts of these investments due to fluctuations in foreign currency exchange rates. In addition, the Company may use non-derivative financial instruments, such as its foreign currency-denominated debt, as economic hedges of its net investments in certain foreign subsidiaries. In both of these cases, the Company designates these instruments as net investment hedges. The Company may also enter into non-designated foreign currency contracts to partially offset the foreign currency exchange gains and losses generated by the re-measurement of certain assets and liabilities denominated in non-functional currencies. The Company may enter into interest rate swaps, options, or other instruments to manage interest rate risk. These instruments may offset a portion of changes in income or expense, or changes in fair value of the Company’s term debt or investments. The Company designates these instruments as either cash flow or fair value hedges. The Company’s hedged interest rate transactions as of March 26, 2016 are expected to be recognized within ten years. Cash Flow Hedges The effective portions of cash flow hedges are recorded in accumulated other comprehensive income (“AOCI”) until the hedged item is recognized in earnings. Deferred gains and losses associated with cash flow hedges of foreign currency revenue are recognized as a component of net sales in the same period as the related revenue is recognized, and deferred gains and losses related to cash flow hedges of inventory purchases are recognized as a component of cost of sales in the same period as the related costs are recognized. Deferred gains and losses associated with cash flow hedges of interest income or expense are recognized in other income/(expense), net in the same period as the related income or expense is recognized. The ineffective portions and amounts excluded from the effectiveness testing of cash flow hedges are recognized in other income/(expense), net. Derivative instruments designated as cash flow hedges must be de-designated as hedges when it is probable the forecasted hedged transaction will not occur in the initially identified time period or within a subsequent two-month time period. Deferred gains and losses in AOCI associated with such derivative instruments are reclassified immediately into other income/(expense), net. Any subsequent changes in fair value of such derivative instruments are reflected in other income/(expense), net unless they are re-designated as hedges of other transactions. Net Investment Hedges The effective portions of net investment hedges are recorded in other comprehensive income (“OCI”) as a part of the cumulative translation adjustment. The ineffective portions and amounts excluded from the effectiveness testing of net investment hedges are recognized in other income/(expense), net. Fair Value Hedges Gains and losses related to changes in fair value hedges are recognized in earnings along with a corresponding loss or gain related to the change in value of the underlying hedged item. Non-Designated Derivatives Derivatives that are not designated as hedging instruments are adjusted to fair value through earnings in the financial statement line item to which the derivative relates.

Summary of Significant Accoun19

Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Mar. 26, 2016
Computation of Basic and Diluted Earnings Per Share	The following table shows the computation of basic and diluted earnings per share for the three- and six-month periods ended March 26, 2016 and March 28, 2015 (net income in millions and shares in thousands): Three Months Ended Six Months Ended March 26, 2016 March 28, 2015 March 26, 2016 March 28, 2015 Numerator: Net income $ 10,516 $ 13,569 $ 28,877 $ 31,593 Denominator: Weighted-average shares outstanding 5,514,381 5,793,799 5,536,656 5,818,441 Effect of dilutive securities 26,505 41,059 30,850 39,889 Weighted-average diluted shares 5,540,886 5,834,858 5,567,506 5,858,330 Basic earnings per share $ 1.91 $ 2.34 $ 5.22 $ 5.43 Diluted earnings per share $ 1.90 $ 2.33 $ 5.19 $ 5.39

Financial Instruments (Tables)

Financial Instruments (Tables)	6 Months Ended
	Mar. 26, 2016
Cash and Available-for-Sale Securities' Adjusted Cost, Gross Unrealized Gains, Gross Unrealized Losses and Fair Value Recorded as Cash and Cash Equivalents or Short-Term or Long-Term Marketable Securities	The following tables show the Company’s cash and available-for-sale March 26, 2016 Adjusted Cost Unrealized Gains Unrealized Losses Fair Value Cash and Cash Equivalents Short-Term Marketable Securities Long-Term Marketable Securities Cash $ 10,199 $ 0 $ 0 $ 10,199 $ 10,199 $ 0 $ 0 Level 1 (1) Money market funds 2,798 0 0 2,798 2,798 0 0 Mutual funds 1,772 0 (203 ) 1,569 0 1,569 0 Subtotal 4,570 0 (203 ) 4,367 2,798 1,569 0 Level 2 (2) U.S. Treasury securities 47,883 207 (24 ) 48,066 3,753 10,614 33,699 U.S. agency securities 6,641 12 (2 ) 6,651 465 2,703 3,483 Non-U.S. government securities 6,873 91 (121 ) 6,843 0 696 6,147 Certificates of deposit and time deposits 4,169 0 0 4,169 1,529 660 1,980 Commercial paper 4,500 0 0 4,500 2,681 1,819 0 Corporate securities 129,394 543 (1,074 ) 128,863 89 15,553 113,221 Municipal securities 952 6 0 958 0 72 886 Mortgage- and asset-backed securities 18,268 86 (42 ) 18,312 0 83 18,229 Subtotal 218,680 945 (1,263 ) 218,362 8,517 32,200 177,645 Total $ 233,449 $ 945 $ (1,466 ) $ 232,928 $ 21,514 $ 33,769 $ 177,645 September 26, 2015 Adjusted Cost Unrealized Gains Unrealized Losses Fair Value Cash and Cash Equivalents Short-Term Marketable Long-Term Marketable Securities Cash $ 11,389 $ 0 $ 0 $ 11,389 $ 11,389 $ 0 $ 0 Level 1 (1) Money market funds 1,798 0 0 1,798 1,798 0 0 Mutual funds 1,772 0 (144 ) 1,628 0 1,628 0 Subtotal 3,570 0 (144 ) 3,426 1,798 1,628 0 Level 2 (2) U.S. Treasury securities 34,902 181 (1 ) 35,082 0 3,498 31,584 U.S. agency securities 5,864 14 0 5,878 841 767 4,270 Non-U.S. government securities 6,356 45 (167 ) 6,234 43 135 6,056 Certificates of deposit and time deposits 4,347 0 0 4,347 2,065 1,405 877 Commercial paper 6,016 0 0 6,016 4,981 1,035 0 Corporate securities 116,908 242 (985 ) 116,165 3 11,948 104,214 Municipal securities 947 5 0 952 0 48 904 Mortgage- and asset-backed securities 16,121 87 (31 ) 16,177 0 17 16,160 Subtotal 191,461 574 (1,184 ) 190,851 7,933 18,853 164,065 Total $ 206,420 $ 574 $ (1,328 ) $ 205,666 $ 21,120 $ 20,481 $ 164,065 (1) The fair value of Level 1 securities is estimated based on quoted prices in active markets for identical assets or liabilities. (2) The fair value of Level 2 securities is estimated based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Cash and Available-for-Sale Securities' Adjusted Cost, Gross Unrealized Gains, Gross Unrealized Losses and Fair Value Recorded as Cash and Cash Equivalents or Short-Term or Long-Term Marketable Securities	The following tables show the Company’s cash and available-for-sale March 26, 2016 Adjusted Cost Unrealized Gains Unrealized Losses Fair Value Cash and Cash Equivalents Short-Term Marketable Securities Long-Term Marketable Securities Cash $ 10,199 $ 0 $ 0 $ 10,199 $ 10,199 $ 0 $ 0 Level 1 (1) Money market funds 2,798 0 0 2,798 2,798 0 0 Mutual funds 1,772 0 (203 ) 1,569 0 1,569 0 Subtotal 4,570 0 (203 ) 4,367 2,798 1,569 0 Level 2 (2) U.S. Treasury securities 47,883 207 (24 ) 48,066 3,753 10,614 33,699 U.S. agency securities 6,641 12 (2 ) 6,651 465 2,703 3,483 Non-U.S. government securities 6,873 91 (121 ) 6,843 0 696 6,147 Certificates of deposit and time deposits 4,169 0 0 4,169 1,529 660 1,980 Commercial paper 4,500 0 0 4,500 2,681 1,819 0 Corporate securities 129,394 543 (1,074 ) 128,863 89 15,553 113,221 Municipal securities 952 6 0 958 0 72 886 Mortgage- and asset-backed securities 18,268 86 (42 ) 18,312 0 83 18,229 Subtotal 218,680 945 (1,263 ) 218,362 8,517 32,200 177,645 Total $ 233,449 $ 945 $ (1,466 ) $ 232,928 $ 21,514 $ 33,769 $ 177,645 September 26, 2015 Adjusted Cost Unrealized Gains Unrealized Losses Fair Value Cash and Cash Equivalents Short-Term Marketable Long-Term Marketable Securities Cash $ 11,389 $ 0 $ 0 $ 11,389 $ 11,389 $ 0 $ 0 Level 1 (1) Money market funds 1,798 0 0 1,798 1,798 0 0 Mutual funds 1,772 0 (144 ) 1,628 0 1,628 0 Subtotal 3,570 0 (144 ) 3,426 1,798 1,628 0 Level 2 (2) U.S. Treasury securities 34,902 181 (1 ) 35,082 0 3,498 31,584 U.S. agency securities 5,864 14 0 5,878 841 767 4,270 Non-U.S. government securities 6,356 45 (167 ) 6,234 43 135 6,056 Certificates of deposit and time deposits 4,347 0 0 4,347 2,065 1,405 877 Commercial paper 6,016 0 0 6,016 4,981 1,035 0 Corporate securities 116,908 242 (985 ) 116,165 3 11,948 104,214 Municipal securities 947 5 0 952 0 48 904 Mortgage- and asset-backed securities 16,121 87 (31 ) 16,177 0 17 16,160 Subtotal 191,461 574 (1,184 ) 190,851 7,933 18,853 164,065 Total $ 206,420 $ 574 $ (1,328 ) $ 205,666 $ 21,120 $ 20,481 $ 164,065 (1) The fair value of Level 1 securities is estimated based on quoted prices in active markets for identical assets or liabilities. (2) The fair value of Level 2 securities is estimated based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Derivative Instruments at Gross Fair Value	The following tables show the Company’s derivative instruments at gross fair value as of March 26, 2016 and September 26, 2015 (in millions): March 26, 2016 Fair Value of Derivatives Designated as Hedge Instruments Fair Value of Derivatives Not Designated as Hedge Instruments Total Fair Value Derivative assets (1) Foreign exchange contracts $ 564 $ 69 $ 633 Interest rate contracts $ 557 $ 0 $ 557 Derivative liabilities (2) Foreign exchange contracts $ 1,033 $ 243 $ 1,276 Interest rate contracts $ 36 $ 0 $ 36 September 26, 2015 Fair Value of as Hedge Instruments Fair Value of Derivatives Not Designated Total Fair Value Derivative assets (1) Foreign exchange contracts $ 1,442 $ 109 $ 1,551 Interest rate contracts $ 394 $ 0 $ 394 Derivative liabilities (2) Foreign exchange contracts $ 905 $ 94 $ 999 Interest rate contracts $ 13 $ 0 $ 13 (1) The fair value of derivative assets is measured using Level 2 fair value inputs and is recorded as other current assets in the Condensed Consolidated Balance Sheets. (2) The fair value of derivative liabilities is measured using Level 2 fair value inputs and is recorded as accrued expenses in the Condensed Consolidated Balance Sheets.
Pre-Tax Gains and Losses of Derivative and Non-Derivative Instruments Designated as Cash Flow, Net Investment and Fair Value Hedges	The following table shows the pre-tax gains and losses of the Company’s derivative and non-derivative instruments designated as cash flow, net investment and fair value hedges on OCI and the Condensed Consolidated Statements of Operations for the three- and six-month periods ended March 26, 2016 and March 28, 2015 (in millions): Three Months Ended Six Months Ended March 26, 2016 March 28, 2015 March 26, 2016 March 28, 2015 Gains/(Losses) recognized in OCI – effective portion: Cash flow hedges: Foreign exchange contracts $ (138 ) $ 1,249 $ 188 $ 3,750 Interest rate contracts (50 ) (87 ) (42 ) (91 ) Total $ (188 ) $ 1,162 $ 146 $ 3,659 Net investment hedges: Foreign exchange contracts $ 0 $ (6 ) $ 0 $ 112 Foreign currency debt (87 ) 0 (77 ) 0 Total $ (87 ) $ (6 ) $ (77 ) $ 112 Gains/(Losses) reclassified from AOCI into net income – effective portion: Cash flow hedges: Foreign exchange contracts $ 668 $ 818 $ 1,183 $ 1,485 Interest rate contracts (3 ) (5 ) (7 ) (9 ) Total $ 665 $ 813 $ 1,176 $ 1,476 Gains/(Losses) on derivative instruments: Fair value hedges: Interest rate contracts $ 250 $ 122 $ 139 $ 239 Gains/(Losses) related to hedged items: Fair value hedges: Interest rate contracts $ (250 ) $ (122 ) $ (139 ) $ (239 )
Notional Amounts of Outstanding Derivative Instruments and Credit Risk Amounts Associated with Outstanding or Unsettled Derivative Instruments	The following table shows the notional amounts of the Company’s outstanding derivative instruments and credit risk amounts associated with outstanding or unsettled derivative instruments as of March 26, 2016 and September 26, 2015 (in millions): March 26, 2016 September 26, 2015 Notional Credit Risk Notional Credit Risk Instruments designated as accounting hedges: Foreign exchange contracts $ 41,996 $ 564 $ 70,054 $ 1,385 Interest rate contracts $ 23,750 $ 557 $ 18,750 $ 394 Instruments not designated as accounting hedges: Foreign exchange contracts $ 30,573 $ 69 $ 49,190 $ 109

Condensed Consolidated Financ21

Condensed Consolidated Financial Statement Details (Tables)	6 Months Ended
	Mar. 26, 2016
Property, Plant and Equipment, Net	Property, Plant and Equipment, Net March 26, 2016 September 26, 2015 Land and buildings $ 8,391 $ 6,956 Machinery, equipment and internal-use software 39,723 37,038 Leasehold improvements 5,937 5,263 Gross property, plant and equipment 54,051 49,257 Accumulated depreciation and amortization (30,848 ) (26,786 ) Total property, plant and equipment, net $ 23,203 $ 22,471
Other Non-Current Liabilities	Other Non-Current Liabilities March 26, 2016 September 26, 2015 Deferred tax liabilities $ 22,955 $ 24,062 Other non-current liabilities 10,904 9,365 Total other non-current liabilities $ 33,859 $ 33,427
Other Income/(Expense), Net	Other Income/(Expense), Net The following table shows the detail of other income/(expense), net for the three- and six-month periods ended March 26, 2016 and March 28, 2015 (in millions): Three Months Ended Six Months Ended March 26, 2016 March 28, 2015 March 26, 2016 March 28, 2015 Interest and dividend income $ 986 $ 675 $ 1,927 $ 1,329 Interest expense (321 ) (163 ) (597 ) (294 ) Other expense, net (510 ) (226 ) (773 ) (579 ) Total other income/(expense), net $ 155 $ 286 $ 557 $ 456

Acquired Intangible Assets (Tab

Acquired Intangible Assets (Tables)	6 Months Ended
	Mar. 26, 2016
Components of Gross and Net Acquired Intangible Asset Balances	The following table summarizes the components of gross and net acquired intangible asset balances as of March 26, 2016 and September 26, 2015 (in millions): March 26, 2016 September 26, 2015 Gross Accumulated Net Gross Accumulated Net Definite-lived and amortizable acquired intangible assets $ 8,797 $ (5,054 ) $ 3,743 $ 8,125 $ (4,332 ) $ 3,793 Indefinite-lived and non-amortizable acquired intangible assets 100 0 100 100 0 100 Total acquired intangible assets $ 8,897 $ (5,054 ) $ 3,843 $ 8,225 $ (4,332 ) $ 3,893
Components of Gross and Net Acquired Intangible Asset Balances	The following table summarizes the components of gross and net acquired intangible asset balances as of March 26, 2016 and September 26, 2015 (in millions): March 26, 2016 September 26, 2015 Gross Accumulated Net Gross Accumulated Net Definite-lived and amortizable acquired intangible assets $ 8,797 $ (5,054 ) $ 3,743 $ 8,125 $ (4,332 ) $ 3,793 Indefinite-lived and non-amortizable acquired intangible assets 100 0 100 100 0 100 Total acquired intangible assets $ 8,897 $ (5,054 ) $ 3,843 $ 8,225 $ (4,332 ) $ 3,893

Debt (Tables)

Debt (Tables)	6 Months Ended
	Mar. 26, 2016
Summary of Cash Flows Associated With Issuance and Maturities of Commercial Paper	The following table provides a summary of cash flows associated with the issuance and maturities of Commercial Paper for the six months ended March 26, 2016 and March 28, 2015 (in millions): Six Months Ended March 26, 2016 March 28, 2015 Maturities less than 90 days: Proceeds from (repayments of) commercial paper, net $ 660 $ 985 Maturities greater than 90 days: Proceeds from commercial paper 669 547 Repayments of commercial paper (1,832 ) (4,040 ) Proceeds from (repayments of) commercial paper, net (1,163 ) (3,493 ) Total change in commercial paper, net $ (503 ) $ (2,508 )
Summary of Term Debt	The following table provides a summary of the Company’s term debt as of March 26, 2016 and September 26, 2015: March, 26, 2016 September 26, 2015 Maturities Amount Effective Interest Rate Amount Effective Interest Rate 2013 debt issuance of $17.0 billion: Floating-rate notes 2016 - 2018 $ 3,000 0.51% - 1.10% $ 3,000 0.51% - 1.10% Fixed-rate 0.45% - 3.85% notes 2016 - 2043 14,000 0.51% - 3.91% 14,000 0.51% - 3.91% 2014 debt issuance of $12.0 billion: Floating-rate notes 2017 - 2019 2,000 0.69% - 0.92% 2,000 0.37% - 0.60% Fixed-rate 1.05% - 4.45% notes 2017 - 2044 10,000 0.69% - 4.48% 10,000 0.37% - 4.48% 2015 debt issuances of $27.3 billion: Floating-rate notes 2017 - 2020 1,781 0.67% - 1.87% 1,743 0.36% - 1.87% Fixed-rate 0.35% - 4.375% notes 2017 - 2045 25,063 0.28% - 4.51% 24,958 0.28% - 4.51% Second quarter 2016 debt issuance of $15.5 billion: Floating-rate notes 2019 500 1.44% 0 0 Floating-rate notes 2021 500 1.75% 0 0 Fixed-rate 1.30% notes 2018 500 1.32% 0 0 Fixed-rate 1.70% notes 2019 1,000 1.71% 0 0 Fixed-rate 2.25% notes 2021 3,000 1.80% 0 0 Fixed-rate 2.85% notes 2023 1,500 2.48% 0 0 Fixed-rate 3.25% notes 2026 3,250 2.33% 0 0 Fixed-rate 4.50% notes 2036 1,250 4.54% 0 0 Fixed-rate 4.65% notes 2046 4,000 4.58% 0 0 Total debt issuance 15,500 0 Total term debt 71,344 55,701 Unamortized premium/(discount) 15 (114 ) Hedge accounting fair value adjustments 515 376 Less: Current portion of long-term debt (2,500 ) (2,500 ) Total long-term debt $ 69,374 $ 53,463

Shareholders' Equity (Tables)

Shareholders' Equity (Tables)	6 Months Ended
	Mar. 26, 2016
Cash Dividends Declared and Paid Per Share	The Company declared and paid cash dividends per share during the periods presented as follows: Dividends Per Share Amount 2016: Second quarter $ 0.52 $ 2,879 First quarter 0.52 2,898 Total cash dividends declared and paid $ 1.04 $ 5,777 2015: Fourth quarter $ 0.52 $ 2,950 Third quarter 0.52 2,997 Second quarter 0.47 2,734 First quarter 0.47 2,750 Total cash dividends declared and paid $ 1.98 $ 11,431
Accelerated Share Repurchase Activity and Related Information	The following table shows the Company’s ASR activity and related information during the six months ended March 26, 2016 and the year ended September 26, 2015: Purchase Period Number of Shares Average ASR Amount November 2015 ASR April 2016 20,382 (1) $ (1) $ 3,000 May 2015 ASR July 2015 48,293 $ 124.24 $ 6,000 August 2014 ASR February 2015 81,525 $ 110.40 $ 9,000 January 2014 ASR December 2014 134,247 $ 89.39 $ 12,000 (1) “Number of Shares” represents those shares delivered in the beginning of the purchase period and does not represent the final number of shares to be delivered under the ASR. The total number of shares ultimately delivered, and therefore the average repurchase price paid per share, will be determined at the end of the applicable purchase period based on the volume-weighted average price of the Company’s common stock during that period. The November 2015 ASR purchase period will end in or before April 2016.
Repurchases of Common Shares in Open Market	Additionally, the Company repurchased shares of its common stock in the open market, which were retired upon repurchase, during the periods presented as follows: Number of Shares Average Repurchase Amount 2016: Second quarter 71,766 $ 97.54 $ 7,000 First quarter 25,984 $ 115.45 3,000 Total open market common stock repurchases 97,750 $ 10,000 2015: Fourth quarter 121,802 $ 115.15 $ 14,026 Third quarter 31,231 $ 128.08 4,000 Second quarter 56,400 $ 124.11 7,000 First quarter 45,704 $ 109.40 5,000 Total open market common stock repurchases 255,137 $ 30,026

Comprehensive Income (Tables)

Comprehensive Income (Tables)	6 Months Ended
	Mar. 26, 2016
Pre-tax Amounts Reclassified from AOCI into Condensed Consolidated Statements of Operations	The following table shows the pre-tax amounts reclassified from AOCI into the Condensed Consolidated Statements of Operations, and the associated financial statement line item, for the three- and six-month periods ended March 26, 2016 and March 28, 2015 (in millions): Three Months Ended Six Months Ended Comprehensive Income Components Financial Statement Line Item March 26, 2016 March 28, March 26, 2016 March 28, Unrealized (gains)/losses on derivative instruments: Foreign exchange contracts Revenue $ (325 ) $ (558 ) $ (654 ) $ (1,007 ) Cost of sales (219 ) (608 ) (525 ) (921 ) Other income/(expense), net (131 ) 348 (11 ) 443 Interest rate contracts Other income/(expense), net 3 4 7 8 (672 ) (814 ) (1,183 ) (1,477 ) Unrealized (gains)/losses on marketable securities Other income/(expense), net 76 56 149 34 Total amounts reclassified from AOCI $ (596 ) $ (758 ) $ (1,034 ) $ (1,443 )
Change in Accumulated Other Comprehensive Income by Component	The following table shows the changes in AOCI by component for the six months ended March 26, 2016 (in millions): Cumulative Unrealized Unrealized Total Balance at September 26, 2015 $ (653 ) $ 772 $ (464 ) $ (345 ) Other comprehensive income/(loss) before reclassifications 18 146 69 233 Amounts reclassified from AOCI 0 (1,183 ) 149 (1,034 ) Tax effect 0 173 (75 ) 98 Other comprehensive income/(loss) 18 (864 ) 143 (703 ) Balance at March 26, 2016 $ (635 ) $ (92 ) $ (321 ) $ (1,048 )

Benefit Plans (Tables)

Benefit Plans (Tables)	6 Months Ended
	Mar. 26, 2016
Restricted Stock Activity	A summary of the Company’s RSU activity and related information for the six months ended March 26, 2016 is as follows: Number of Weighted-Average Grant Date Fair Aggregate Balance at September 26, 2015 101,467 $ 85.77 RSUs granted 43,513 $ 110.57 RSUs vested (22,353 ) $ 78.86 RSUs cancelled (2,413 ) $ 93.43 Balance at March 26, 2016 120,214 $ 95.80 $ 12,703
Summary of Share-Based Compensation Expense	The following table shows a summary of the share-based compensation expense included in the Condensed Consolidated Statements of Operations for the three- and six-month periods ended March 26, 2016 and March 28, 2015 (in millions): Three Months Ended Six Months Ended March 26, March 28, March 26, March 28, Cost of sales $ 191 $ 142 $ 395 $ 282 Research and development 468 384 934 758 Selling, general and administrative 389 401 797 775 Total share-based compensation expense $ 1,048 $ 927 $ 2,126 $ 1,815

Commitments and Contingencies (

Commitments and Contingencies (Tables)	6 Months Ended
	Mar. 26, 2016
Changes in Accrued Warranties and Related Costs	The following table shows changes in the Company’s accrued warranties and related costs for the three- and six-month periods ended March 26, 2016 and March 28, 2015 (in millions): Three Months Ended Six Months Ended March 26, March 28, March 26, March 28, Beginning accrued warranty and related costs $ 5,236 $ 5,195 $ 4,780 $ 4,159 Cost of warranty claims (1,128 ) (1,030 ) (2,397 ) (2,074 ) Accruals for product warranty 877 978 2,602 3,058 Ending accrued warranty and related costs $ 4,985 $ 5,143 $ 4,985 $ 5,143

Segment Information and Geogr28

Segment Information and Geographic Data (Tables)	6 Months Ended
	Mar. 26, 2016
Summary Information by Operating Segment	The following table shows information by reportable operating segment for the three- and six-month periods ended March 26, 2016 and March 28, 2015 (in millions): Three Months Ended Six Months Ended March 26, 2016 March 28, 2015 March 26, 2016 March 28, 2015 Americas: Net sales $ 19,096 $ 21,316 $ 48,421 $ 51,882 Operating income $ 6,116 $ 7,186 $ 16,134 $ 17,887 Europe: Net sales $ 11,535 $ 12,204 $ 29,467 $ 29,418 Operating income $ 3,602 $ 4,112 $ 9,381 $ 9,994 Greater China: Net sales $ 12,486 $ 16,823 $ 30,859 $ 32,967 Operating income $ 4,818 $ 6,714 $ 12,394 $ 13,080 Japan: Net sales $ 4,281 $ 3,457 $ 9,075 $ 8,905 Operating income $ 1,930 $ 1,699 $ 4,170 $ 4,187 Rest of Asia Pacific: Net sales $ 3,159 $ 4,210 $ 8,607 $ 9,437 Operating income $ 1,095 $ 1,600 $ 3,127 $ 3,449
Reconciliation of Segment Operating Income to Condensed Consolidated Statements of Operations	A reconciliation of the Company’s segment operating income to the Condensed Consolidated Statements of Operations for the three- and six-month periods ended March 26, 2016 and March 28, 2015 (in millions): Three Months Ended Six Months Ended March 26, 2016 March 28, 2015 March 26, 2016 March 28, 2015 Segment operating income $ 17,561 $ 21,311 $ 45,206 $ 48,597 Research and development expense (2,511 ) (1,918 ) (4,915 ) (3,813 ) Other corporate expenses, net (1,063 ) (1,115 ) (2,133 ) (2,260 ) Total operating income $ 13,987 $ 18,278 $ 38,158 $ 42,524

Computation of Basic and Dilute

Computation of Basic and Diluted Earnings Per Share (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended		6 Months Ended
	Mar. 26, 2016	Mar. 28, 2015	Mar. 26, 2016	Mar. 28, 2015
Numerator:
Net income	$ 10,516	$ 13,569	$ 28,877	$ 31,593
Denominator:
Weighted-average shares outstanding	5,514,381	5,793,799	5,536,656	5,818,441
Effect of dilutive securities	26,505	41,059	30,850	39,889
Weighted-average diluted shares	5,540,886	5,834,858	5,567,506	5,858,330
Basic earnings per share	$ 1.91	$ 2.34	$ 5.22	$ 5.43
Diluted earnings per share	$ 1.90	$ 2.33	$ 5.19	$ 5.39

Cash and Available-for-Sale Sec

Cash and Available-for-Sale Securities' Adjusted Cost, Gross Unrealized Gains, Gross Unrealized Losses and Fair Value Recorded as Cash and Cash Equivalents or Short-Term or Long-Term Marketable Securities (Detail) - USD ($) $ in Millions		Mar. 26, 2016	Sep. 26, 2015	Mar. 28, 2015	Sep. 27, 2014
Schedule of Available-for-sale Securities [Line Items]
Adjusted Cost		$ 233,449	$ 206,420
Unrealized Gains		945	574
Unrealized Losses		(1,466)	(1,328)
Fair Value		232,928	205,666
Cash and cash equivalents		21,514	21,120	$ 14,489	$ 13,844
Short-term marketable securities		33,769	20,481
Long-term marketable securities		177,645	164,065
Cash
Schedule of Available-for-sale Securities [Line Items]
Adjusted Cost		10,199	11,389
Unrealized Gains		0	0
Unrealized Losses		0	0
Fair Value		10,199	11,389
Cash and cash equivalents		10,199	11,389
Short-term marketable securities		0	0
Long-term marketable securities		0	0
Level 1
Schedule of Available-for-sale Securities [Line Items]
Adjusted Cost	[1]	4,570	3,570
Unrealized Gains	[1]	0	0
Unrealized Losses	[1]	(203)	(144)
Fair Value	[1]	4,367	3,426
Cash and cash equivalents	[1]	2,798	1,798
Short-term marketable securities	[1]	1,569	1,628
Long-term marketable securities	[1]	0	0
Level 1 | Money market funds
Schedule of Available-for-sale Securities [Line Items]
Adjusted Cost	[1]	2,798	1,798
Unrealized Gains	[1]	0	0
Unrealized Losses	[1]	0	0
Fair Value	[1]	2,798	1,798
Cash and cash equivalents	[1]	2,798	1,798
Short-term marketable securities	[1]	0	0
Long-term marketable securities	[1]	0	0
Level 1 | Mutual funds
Schedule of Available-for-sale Securities [Line Items]
Adjusted Cost	[1]	1,772	1,772
Unrealized Gains	[1]	0	0
Unrealized Losses	[1]	(203)	(144)
Fair Value	[1]	1,569	1,628
Cash and cash equivalents	[1]	0	0
Short-term marketable securities	[1]	1,569	1,628
Long-term marketable securities	[1]	0	0
Level 2
Schedule of Available-for-sale Securities [Line Items]
Adjusted Cost	[2]	218,680	191,461
Unrealized Gains	[2]	945	574
Unrealized Losses	[2]	(1,263)	(1,184)
Fair Value	[2]	218,362	190,851
Cash and cash equivalents	[2]	8,517	7,933
Short-term marketable securities	[2]	32,200	18,853
Long-term marketable securities	[2]	177,645	164,065
Level 2 | U.S. Treasury securities
Schedule of Available-for-sale Securities [Line Items]
Adjusted Cost	[2]	47,883	34,902
Unrealized Gains	[2]	207	181
Unrealized Losses	[2]	(24)	(1)
Fair Value	[2]	48,066	35,082
Cash and cash equivalents	[2]	3,753	0
Short-term marketable securities	[2]	10,614	3,498
Long-term marketable securities	[2]	33,699	31,584
Level 2 | U.S. agency securities
Schedule of Available-for-sale Securities [Line Items]
Adjusted Cost	[2]	6,641	5,864
Unrealized Gains	[2]	12	14
Unrealized Losses	[2]	(2)	0
Fair Value	[2]	6,651	5,878
Cash and cash equivalents	[2]	465	841
Short-term marketable securities	[2]	2,703	767
Long-term marketable securities	[2]	3,483	4,270
Level 2 | Non-U.S. government securities
Schedule of Available-for-sale Securities [Line Items]
Adjusted Cost	[2]	6,873	6,356
Unrealized Gains	[2]	91	45
Unrealized Losses	[2]	(121)	(167)
Fair Value	[2]	6,843	6,234
Cash and cash equivalents	[2]	0	43
Short-term marketable securities	[2]	696	135
Long-term marketable securities	[2]	6,147	6,056
Level 2 | Certificates of deposit and time deposits
Schedule of Available-for-sale Securities [Line Items]
Adjusted Cost	[2]	4,169	4,347
Unrealized Gains	[2]	0	0
Unrealized Losses	[2]	0	0
Fair Value	[2]	4,169	4,347
Cash and cash equivalents	[2]	1,529	2,065
Short-term marketable securities	[2]	660	1,405
Long-term marketable securities	[2]	1,980	877
Level 2 | Commercial paper
Schedule of Available-for-sale Securities [Line Items]
Adjusted Cost	[2]	4,500	6,016
Unrealized Gains	[2]	0	0
Unrealized Losses	[2]	0	0
Fair Value	[2]	4,500	6,016
Cash and cash equivalents	[2]	2,681	4,981
Short-term marketable securities	[2]	1,819	1,035
Long-term marketable securities	[2]	0	0
Level 2 | Corporate securities
Schedule of Available-for-sale Securities [Line Items]
Adjusted Cost	[2]	129,394	116,908
Unrealized Gains	[2]	543	242
Unrealized Losses	[2]	(1,074)	(985)
Fair Value	[2]	128,863	116,165
Cash and cash equivalents	[2]	89	3
Short-term marketable securities	[2]	15,553	11,948
Long-term marketable securities	[2]	113,221	104,214
Level 2 | Municipal securities
Schedule of Available-for-sale Securities [Line Items]
Adjusted Cost	[2]	952	947
Unrealized Gains	[2]	6	5
Unrealized Losses	[2]	0	0
Fair Value	[2]	958	952
Cash and cash equivalents	[2]	0	0
Short-term marketable securities	[2]	72	48
Long-term marketable securities	[2]	886	904
Level 2 | Mortgage- and asset-backed securities
Schedule of Available-for-sale Securities [Line Items]
Adjusted Cost	[2]	18,268	16,121
Unrealized Gains	[2]	86	87
Unrealized Losses	[2]	(42)	(31)
Fair Value	[2]	18,312	16,177
Cash and cash equivalents	[2]	0	0
Short-term marketable securities	[2]	83	17
Long-term marketable securities	[2]	$ 18,229	$ 16,160
[1]	The fair value of Level 1 securities is estimated based on quoted prices in active markets for identical assets or liabilities.
[2]	The fair value of Level 2 securities is estimated based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Financial Instruments - Additio

Financial Instruments - Additional Information (Detail) $ in Millions	6 Months Ended	12 Months Ended
	Mar. 26, 2016USD ($)VendorCustomer	Sep. 26, 2015USD ($)VendorCustomer
Financial Instruments [Line Items]
Maturities of long-term marketable securities, minimum	1 year
Maturities of long-term marketable securities, maximum	5 years
Hedged foreign currency transactions, typical term	12 months
Hedged interest rate transactions, expected period to be recognized	10 years
Net cash collateral posted, derivative instruments	$ 3
Net cash collateral received, derivative instruments		$ 1,000
Reduction to derivative assets by rights of set-off associated with derivative contracts	1,400	2,200
Reduction to derivative liabilities by rights of set-off associated with derivative contracts	1,400	2,200
Net derivative assets (liabilities)	$ (119)	$ (78)
Number of customers representing a significant portion of trade receivables | Customer	1	1
Number of vendors representing a significant portion of non-trade receivables | Vendor	3	3
Trade Receivables | Credit Concentration Risk | Customer One
Financial Instruments [Line Items]
Concentration risk, percentage	12.00%	12.00%
Trade Receivables | Credit Concentration Risk | Cellular Network Carriers
Financial Instruments [Line Items]
Concentration risk, percentage	55.00%	71.00%
Non-Trade Receivables | Credit Concentration Risk | Vendor One
Financial Instruments [Line Items]
Concentration risk, percentage	55.00%	38.00%
Non-Trade Receivables | Credit Concentration Risk | Vendor Two
Financial Instruments [Line Items]
Concentration risk, percentage	14.00%	18.00%
Non-Trade Receivables | Credit Concentration Risk | Vendor Three
Financial Instruments [Line Items]
Concentration risk, percentage	11.00%	14.00%

Derivative Instruments at Gross

Derivative Instruments at Gross Fair Value (Detail) - Level 2 - USD ($) $ in Millions		Mar. 26, 2016	Sep. 26, 2015
Foreign exchange contracts | Other Current Assets
Derivative assets:
Fair Value of Derivative Assets	[1]	$ 633	$ 1,551
Foreign exchange contracts | Accrued expenses
Derivative liabilities:
Fair Value of Derivative Liabilities	[2]	1,276	999
Interest rate contracts | Other Current Assets
Derivative assets:
Fair Value of Derivative Assets	[1]	557	394
Interest rate contracts | Accrued expenses
Derivative liabilities:
Fair Value of Derivative Liabilities	[2]	36	13
Derivatives Designated as Hedging Instruments | Foreign exchange contracts | Other Current Assets
Derivative assets:
Fair Value of Derivative Assets	[1]	564	1,442
Derivatives Designated as Hedging Instruments | Foreign exchange contracts | Accrued expenses
Derivative liabilities:
Fair Value of Derivative Liabilities	[2]	1,033	905
Derivatives Designated as Hedging Instruments | Interest rate contracts | Other Current Assets
Derivative assets:
Fair Value of Derivative Assets	[1]	557	394
Derivatives Designated as Hedging Instruments | Interest rate contracts | Accrued expenses
Derivative liabilities:
Fair Value of Derivative Liabilities	[2]	36	13
Not Designated as Hedging Instrument | Foreign exchange contracts | Other Current Assets
Derivative assets:
Fair Value of Derivative Assets	[1]	69	109
Not Designated as Hedging Instrument | Foreign exchange contracts | Accrued expenses
Derivative liabilities:
Fair Value of Derivative Liabilities	[2]	243	94
Not Designated as Hedging Instrument | Interest rate contracts | Other Current Assets
Derivative assets:
Fair Value of Derivative Assets	[1]	0	0
Not Designated as Hedging Instrument | Interest rate contracts | Accrued expenses
Derivative liabilities:
Fair Value of Derivative Liabilities	[2]	$ 0	$ 0
[1]	The fair value of derivative assets is measured using Level 2 fair value inputs and is recorded as other current assets in the Condensed Consolidated Balance Sheets.
[2]	The fair value of derivative liabilities is measured using Level 2 fair value inputs and is recorded as accrued expenses in the Condensed Consolidated Balance Sheets.

Pre-Tax Gains and Losses of Der

Pre-Tax Gains and Losses of Derivative and Non-Derivative Instruments Designated as Cash Flow, Net Investment and Fair Value Hedges (Detail) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 26, 2016	Mar. 28, 2015	Mar. 26, 2016	Mar. 28, 2015
Cash flow hedges
Derivative Instruments, Gain (Loss) [Line Items]
Gains/(Losses) recognized in OCI - effective portion	$ (188)	$ 1,162	$ 146	$ 3,659
Gains/(Losses) reclassified from AOCI into net income - effective portion	665	813	1,176	1,476
Cash flow hedges | Foreign exchange contracts
Derivative Instruments, Gain (Loss) [Line Items]
Gains/(Losses) recognized in OCI - effective portion	(138)	1,249	188	3,750
Gains/(Losses) reclassified from AOCI into net income - effective portion	668	818	1,183	1,485
Cash flow hedges | Interest rate contracts
Derivative Instruments, Gain (Loss) [Line Items]
Gains/(Losses) recognized in OCI - effective portion	(50)	(87)	(42)	(91)
Gains/(Losses) reclassified from AOCI into net income - effective portion	(3)	(5)	(7)	(9)
Net investment hedges
Derivative Instruments, Gain (Loss) [Line Items]
Gains/(Losses) recognized in OCI - effective portion	(87)	(6)	(77)	112
Net investment hedges | Foreign exchange contracts
Derivative Instruments, Gain (Loss) [Line Items]
Gains/(Losses) recognized in OCI - effective portion	0	(6)	0	112
Net investment hedges | Foreign currency debt
Derivative Instruments, Gain (Loss) [Line Items]
Gains/(Losses) recognized in OCI - effective portion	(87)	0	(77)	0
Fair value hedges | Interest rate contracts
Derivative Instruments, Gain (Loss) [Line Items]
Gains/(Losses) on derivative instruments	250	122	139	239
Gains/(Losses) related to hedged items	$ (250)	$ (122)	$ (139)	$ (239)

Notional Amounts of Outstanding

Notional Amounts of Outstanding Derivative Instruments and Credit Risk Amounts Associated with Outstanding or Unsettled Derivative Instruments (Detail) - USD ($) $ in Millions	Mar. 26, 2016	Sep. 26, 2015
Derivatives Designated as Hedging Instruments | Foreign exchange contracts
Derivative [Line Items]
Notional Amount	$ 41,996	$ 70,054
Credit Risk	564	1,385
Derivatives Designated as Hedging Instruments | Interest rate contracts
Derivative [Line Items]
Notional Amount	23,750	18,750
Credit Risk	557	394
Not Designated as Hedging Instrument | Foreign exchange contracts
Derivative [Line Items]
Notional Amount	30,573	49,190
Credit Risk	$ 69	$ 109

Property, Plant and Equipment,

Property, Plant and Equipment, Net (Detail) - USD ($) $ in Millions	Mar. 26, 2016	Sep. 26, 2015
Property, Plant and Equipment [Line Items]
Gross property, plant and equipment	$ 54,051	$ 49,257
Accumulated depreciation and amortization	(30,848)	(26,786)
Total property, plant and equipment, net	23,203	22,471
Land and Buildings
Property, Plant and Equipment [Line Items]
Gross property, plant and equipment	8,391	6,956
Machinery, Equipment and Internal-Use Software
Property, Plant and Equipment [Line Items]
Gross property, plant and equipment	39,723	37,038
Leasehold Improvements
Property, Plant and Equipment [Line Items]
Gross property, plant and equipment	$ 5,937	$ 5,263

Other Non-Current Liabilities (

Other Non-Current Liabilities (Detail) - USD ($) $ in Millions	Mar. 26, 2016	Sep. 26, 2015
Schedule of Other Liabilities [Line Items]
Deferred tax liabilities	$ 22,955	$ 24,062
Other non-current liabilities	10,904	9,365
Total other non-current liabilities	$ 33,859	$ 33,427

Other Income_(Expense), Net (De

Other Income/(Expense), Net (Detail) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 26, 2016	Mar. 28, 2015	Mar. 26, 2016	Mar. 28, 2015
Other Income Expense [Line Items]
Interest and dividend income	$ 986	$ 675	$ 1,927	$ 1,329
Interest expense	(321)	(163)	(597)	(294)
Other expense, net	(510)	(226)	(773)	(579)
Total other income/(expense), net	$ 155	$ 286	$ 557	$ 456

Acquired Intangible Assets - Ad

Acquired Intangible Assets - Additional Information (Detail)	6 Months Ended
	Mar. 26, 2016
Minimum
Acquired Finite-Lived Intangible Assets [Line Items]
Amortized acquired intangible assets with definite lives useful period (in years)	3 years
Maximum
Acquired Finite-Lived Intangible Assets [Line Items]
Amortized acquired intangible assets with definite lives useful period (in years)	7 years

Components of Gross and Net Acq

Components of Gross and Net Acquired Intangible Asset Balances (Detail) - USD ($) $ in Millions	Mar. 26, 2016	Sep. 26, 2015
Acquired Intangible Assets [Line Items]
Definite-lived and amortizable acquired intangible assets, Gross Carrying Amount	$ 8,797	$ 8,125
Definite-lived and amortizable acquired intangible assets, Accumulated Amortization	(5,054)	(4,332)
Definite-lived and amortizable acquired intangible assets, Net Carrying Amount	3,743	3,793
Indefinite-lived and non-amortizable acquired intangible assets	100	100
Total acquired intangible assets, Net Carrying Amount	$ 3,843	$ 3,893

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) $ in Millions	Jun. 11, 2014Subsidiary	Mar. 26, 2016USD ($)	Sep. 26, 2015USD ($)
Income Tax Contingency [Line Items]
Gross unrecognized tax benefits		$ 7,500	$ 6,900
Gross unrecognized tax benefits that would affect effective tax rate, if recognized		2,800	2,500
Unrecognized tax benefits, gross interest and penalties accrued		1,500	$ 1,300
Reasonably possible decrease in unrecognized tax benefits in the next 12 months		$ 800
European Commission
Income Tax Contingency [Line Items]
Income Tax Contingency, Number of Subsidiaries | Subsidiary	2
European Commission | Maximum
Income Tax Contingency [Line Items]
Income Tax Contingency, Period of Occurrence	10 years

Debt - Additional Information (

Debt - Additional Information (Detail) $ in Millions, ¥ in Billions	3 Months Ended		6 Months Ended
	Mar. 26, 2016USD ($)	Mar. 28, 2015USD ($)	Mar. 26, 2016USD ($)	Mar. 28, 2015USD ($)	Mar. 26, 2016JPY (¥)	Sep. 26, 2015USD ($)
Debt Instrument [Line Items]
Commercial paper	$ 7,998		$ 7,998			$ 8,499
Debt instrument aggregate principal amount	71,344		71,344			55,701
Interest expense	311	$ 161	582	$ 289
Second quarter 2016 debt issuance
Debt Instrument [Line Items]
Debt instrument, face amount	15,500		15,500
Debt instrument, senior notes	15,500		15,500			0
Net investment hedges | Third quarter 2015 Japanese yen-denominated debt issuance
Debt Instrument [Line Items]
Debt instrument, face amount | ¥					¥ 149.3
Debt instrument, senior notes	1,300		1,300			$ 2,100
Interest Rate Swaps | Second quarter 2016 debt issuance
Debt Instrument [Line Items]
Notional Amount	$ 5,000		$ 5,000
Commercial paper
Debt Instrument [Line Items]
Commercial paper, weighted-average interest rate	0.39%		0.39%		0.39%	0.14%
Commercial paper | Maximum
Debt Instrument [Line Items]
Commercial paper, maturity period			9 months
Level 2
Debt Instrument [Line Items]
Debt instrument fair value	$ 72,400		$ 72,400			$ 54,900

Summary of Cash Flows Associate

Summary of Cash Flows Associated With Issuance and Maturities of Commercial Paper (Detail) - USD ($) $ in Millions	6 Months Ended
	Mar. 26, 2016	Mar. 28, 2015
Maturities less than 90 days:
Proceeds from (repayments of) commercial paper, net	$ 660	$ 985
Maturities greater than 90 days:
Proceeds from commercial paper	669	547
Repayments of commercial paper	(1,832)	(4,040)
Proceeds from (repayments of) commercial paper, net	(1,163)	(3,493)
Total change in commercial paper, net	$ (503)	$ (2,508)

Summary of Term Debt (Detail)

Summary of Term Debt (Detail) - USD ($) $ in Millions	6 Months Ended	12 Months Ended
	Mar. 26, 2016	Sep. 26, 2015
Debt Instrument [Line Items]
Total term debt	$ 71,344	$ 55,701
Unamortized premium/(discount)	15	(114)
Hedge accounting fair value adjustments	515	376
Less: Current portion of long-term debt	(2,500)	(2,500)
Total long-term debt	69,374	53,463
2013 debt issuance | Floating-rate notes
Debt Instrument [Line Items]
Debt instrument, senior notes	$ 3,000	$ 3,000
Debt instrument maturity year, start	2,016	2,016
Debt instrument maturity year, end	2,018	2,018
Debt instrument effective interest rate, minimum	0.51%	0.51%
Debt instrument effective interest rate, maximum	1.10%	1.10%
2013 debt issuance | Fixed-rate 0.45% - 3.85% notes
Debt Instrument [Line Items]
Debt instrument, senior notes	$ 14,000	$ 14,000
Debt instrument maturity year, start	2,016	2,016
Debt instrument maturity year, end	2,043	2,043
Debt instrument effective interest rate, minimum	0.51%	0.51%
Debt instrument effective interest rate, maximum	3.91%	3.91%
2014 debt issuance | Floating-rate notes
Debt Instrument [Line Items]
Debt instrument, senior notes	$ 2,000	$ 2,000
Debt instrument maturity year, start	2,017	2,017
Debt instrument maturity year, end	2,019	2,019
Debt instrument effective interest rate, minimum	0.69%	0.37%
Debt instrument effective interest rate, maximum	0.92%	0.60%
2014 debt issuance | Fixed-rate 1.05% - 4.45% notes
Debt Instrument [Line Items]
Debt instrument, senior notes	$ 10,000	$ 10,000
Debt instrument maturity year, start	2,017	2,017
Debt instrument maturity year, end	2,044	2,044
Debt instrument effective interest rate, minimum	0.69%	0.37%
Debt instrument effective interest rate, maximum	4.48%	4.48%
2015 debt issuances | Floating-rate notes
Debt Instrument [Line Items]
Debt instrument, senior notes	$ 1,781	$ 1,743
Debt instrument maturity year, start	2,017	2,017
Debt instrument maturity year, end	2,020	2,020
Debt instrument effective interest rate, minimum	0.67%	0.36%
Debt instrument effective interest rate, maximum	1.87%	1.87%
2015 debt issuances | Fixed-rate 0.35% - 4.375% notes
Debt Instrument [Line Items]
Debt instrument, senior notes	$ 25,063	$ 24,958
Debt instrument maturity year, start	2,017	2,017
Debt instrument maturity year, end	2,045	2,045
Debt instrument effective interest rate, minimum	0.28%	0.28%
Debt instrument effective interest rate, maximum	4.51%	4.51%
Second quarter 2016 debt issuance
Debt Instrument [Line Items]
Debt instrument, senior notes	$ 15,500	$ 0
Second quarter 2016 debt issuance | Floating-rate notes due 2019
Debt Instrument [Line Items]
Debt instrument, senior notes	$ 500	$ 0
Debt instrument maturity year	2,019	2,019
Debt instrument effective interest rate	1.44%	0.00%
Second quarter 2016 debt issuance | Floating-rate notes due 2021
Debt Instrument [Line Items]
Debt instrument, senior notes	$ 500	$ 0
Debt instrument maturity year	2,021	2,021
Debt instrument effective interest rate	1.75%	0.00%
Second quarter 2016 debt issuance | Fixed-rate 1.30% notes
Debt Instrument [Line Items]
Debt instrument, senior notes	$ 500	$ 0
Debt instrument maturity year	2,018	2,018
Debt instrument effective interest rate	1.32%	0.00%
Second quarter 2016 debt issuance | Fixed-rate 1.70% notes
Debt Instrument [Line Items]
Debt instrument, senior notes	$ 1,000	$ 0
Debt instrument maturity year	2,019	2,019
Debt instrument effective interest rate	1.71%	0.00%
Second quarter 2016 debt issuance | Fixed-rate 2.25% notes
Debt Instrument [Line Items]
Debt instrument, senior notes	$ 3,000	$ 0
Debt instrument maturity year	2,021	2,021
Debt instrument effective interest rate	1.80%	0.00%
Second quarter 2016 debt issuance | Fixed-rate 2.85% notes
Debt Instrument [Line Items]
Debt instrument, senior notes	$ 1,500	$ 0
Debt instrument maturity year	2,023	2,023
Debt instrument effective interest rate	2.48%	0.00%
Second quarter 2016 debt issuance | Fixed-rate 3.25% notes
Debt Instrument [Line Items]
Debt instrument, senior notes	$ 3,250	$ 0
Debt instrument maturity year	2,026	2,026
Debt instrument effective interest rate	2.33%	0.00%
Second quarter 2016 debt issuance | Fixed-rate 4.50% notes
Debt Instrument [Line Items]
Debt instrument, senior notes	$ 1,250	$ 0
Debt instrument maturity year	2,036	2,036
Debt instrument effective interest rate	4.54%	0.00%
Second quarter 2016 debt issuance | Fixed-rate 4.65% notes
Debt Instrument [Line Items]
Debt instrument, senior notes	$ 4,000	$ 0
Debt instrument maturity year	2,046	2,046
Debt instrument effective interest rate	4.58%	0.00%

Summary of Term Debt (Parenthet

Summary of Term Debt (Parenthetical) (Detail) - USD ($) $ in Billions	6 Months Ended	12 Months Ended
	Mar. 26, 2016	Sep. 26, 2015
2013 debt issuance
Debt Instrument [Line Items]
Debt instrument, face amount	$ 17	$ 17
2014 debt issuance
Debt Instrument [Line Items]
Debt instrument, face amount	12	12
2015 debt issuances
Debt Instrument [Line Items]
Debt instrument, face amount	27.3	$ 27.3
Second quarter 2016 debt issuance
Debt Instrument [Line Items]
Debt instrument, face amount	$ 15.5
Fixed-rate 0.45% - 3.85% notes | 2013 debt issuance
Debt Instrument [Line Items]
Debt instrument interest rate, minimum	0.45%	0.45%
Debt instrument interest rate, maximum	3.85%	3.85%
Fixed-rate 1.05% - 4.45% notes | 2014 debt issuance
Debt Instrument [Line Items]
Debt instrument interest rate, minimum	1.05%	1.05%
Debt instrument interest rate, maximum	4.45%	4.45%
Fixed-rate 0.35% - 4.375% notes | 2015 debt issuances
Debt Instrument [Line Items]
Debt instrument interest rate, minimum	0.35%	0.35%
Debt instrument interest rate, maximum	4.375%	4.375%
Fixed-rate 1.30% notes | Second quarter 2016 debt issuance
Debt Instrument [Line Items]
Debt instrument interest rate	1.30%
Fixed-rate 1.70% notes | Second quarter 2016 debt issuance
Debt Instrument [Line Items]
Debt instrument interest rate	1.70%
Fixed-rate 2.25% notes | Second quarter 2016 debt issuance
Debt Instrument [Line Items]
Debt instrument interest rate	2.25%
Fixed-rate 2.85% notes | Second quarter 2016 debt issuance
Debt Instrument [Line Items]
Debt instrument interest rate	2.85%
Fixed-rate 3.25% notes | Second quarter 2016 debt issuance
Debt Instrument [Line Items]
Debt instrument interest rate	3.25%
Fixed-rate 4.50% notes | Second quarter 2016 debt issuance
Debt Instrument [Line Items]
Debt instrument interest rate	4.50%
Fixed-rate 4.65% notes | Second quarter 2016 debt issuance
Debt Instrument [Line Items]
Debt instrument interest rate	4.65%

Summary of Dividends Declared a

Summary of Dividends Declared and Paid (Detail) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended						6 Months Ended		12 Months Ended
	Mar. 26, 2016	Dec. 26, 2015	Sep. 26, 2015	Jun. 27, 2015	Mar. 28, 2015	Dec. 27, 2014	Mar. 26, 2016	Mar. 28, 2015	Sep. 26, 2015
Dividends [Line Items]
Dividend Per Share	$ 0.52	$ 0.52	$ 0.52	$ 0.52	$ 0.47	$ 0.47	$ 1.04	$ 0.94	$ 1.98
Amount	$ 2,879	$ 2,898	$ 2,950	$ 2,997	$ 2,734	$ 2,750	$ 5,777		$ 11,431

Shareholders' Equity - Addition

Shareholders' Equity - Additional Information (Detail) - USD ($)	Mar. 26, 2016	Sep. 26, 2015
Stockholders Equity Note Disclosure [Line Items]
Maximum amount authorized for repurchase of common stock		$ 140,000,000,000
Share repurchase program, utilized amount	$ 117,000,000,000

Accelerated Share Repurchase Ac

Accelerated Share Repurchase Activity and Related Information (Detail) - USD ($) $ / shares in Units, shares in Thousands		3 Months Ended	5 Months Ended	7 Months Ended	12 Months Ended
		Jul. 31, 2015	Mar. 26, 2016	Feb. 28, 2015	Dec. 31, 2014
November 2015 ASR
Accelerated Share Repurchases [Line Items]
Purchase Period End Date			2016-04
Number of Shares	[1]		20,382
Average Repurchase Price Per Share	[1]
ASR Amount			$ 3,000,000,000
May 2015 ASR
Accelerated Share Repurchases [Line Items]
Purchase Period End Date		2015-07
Number of Shares		48,293
Average Repurchase Price Per Share		$ 124.24
ASR Amount		$ 6,000,000,000
August 2014 ASR
Accelerated Share Repurchases [Line Items]
Purchase Period End Date				2015-02
Number of Shares				81,525
Average Repurchase Price Per Share				$ 110.40
ASR Amount				$ 9,000,000,000
January 2014 ASR
Accelerated Share Repurchases [Line Items]
Purchase Period End Date					2014-12
Number of Shares					134,247
Average Repurchase Price Per Share					$ 89.39
ASR Amount					$ 12,000,000,000
[1]	"Number of Shares" represents those shares delivered in the beginning of the purchase period and does not represent the final number of shares to be delivered under the ASR. The total number of shares ultimately delivered, and therefore the average repurchase price paid per share, will be determined at the end of the applicable purchase period based on the volume-weighted average price of the Company's common stock during that period. The November 2015 ASR purchase period will end in or before April 2016.

Repurchases of Common Shares in

Repurchases of Common Shares in Open Market (Detail) - Open Market Repurchases - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended						6 Months Ended	12 Months Ended
	Mar. 26, 2016	Dec. 26, 2015	Sep. 26, 2015	Jun. 27, 2015	Mar. 28, 2015	Dec. 27, 2014	Mar. 26, 2016	Sep. 26, 2015
Stock Repurchase Program [Line Items]
Number of Shares	71,766	25,984	121,802	31,231	56,400	45,704	97,750	255,137
Average Repurchase Price Per Share	$ 97.54	$ 115.45	$ 115.15	$ 128.08	$ 124.11	$ 109.40
Amount	$ 7,000	$ 3,000	$ 14,026	$ 4,000	$ 7,000	$ 5,000	$ 10,000	$ 30,026

Pre-tax Amounts Reclassified fr

Pre-tax Amounts Reclassified from AOCI into Condensed Consolidated Statements of Operations (Detail) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 26, 2016	Mar. 28, 2015	Mar. 26, 2016	Mar. 28, 2015
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Unrealized (gains)/losses on derivative instruments reclassified from AOCI	$ (672)	$ (814)	$ (1,183)	$ (1,477)
Unrealized (gains)/losses on marketable securities reclassified from AOCI	76	56	149	34
Total amounts reclassified from AOCI	(596)	(758)	(1,034)	(1,443)
Foreign exchange contracts | Revenue
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Unrealized (gains)/losses on derivative instruments reclassified from AOCI	(325)	(558)	(654)	(1,007)
Foreign exchange contracts | Cost of sales
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Unrealized (gains)/losses on derivative instruments reclassified from AOCI	(219)	(608)	(525)	(921)
Foreign exchange contracts | Other income/(expense), net
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Unrealized (gains)/losses on derivative instruments reclassified from AOCI	(131)	348	(11)	443
Interest rate contracts | Other income/(expense), net
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Unrealized (gains)/losses on derivative instruments reclassified from AOCI	$ 3	$ 4	$ 7	$ 8

Change in Accumulated Other Com

Change in Accumulated Other Comprehensive Income by Component (Detail) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 26, 2016	Mar. 28, 2015	Mar. 26, 2016	Mar. 28, 2015
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance			$ (345)
Other comprehensive income/(loss) before reclassifications			233
Amounts reclassified from AOCI	$ (596)	$ (758)	(1,034)	$ (1,443)
Tax effect			98
Total other comprehensive income/(loss)	432	$ 747	(703)	$ 1,628
Ending balance	(1,048)		(1,048)
Cumulative Foreign Currency Translation
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance			(653)
Other comprehensive income/(loss) before reclassifications			18
Amounts reclassified from AOCI			0
Tax effect			0
Total other comprehensive income/(loss)			18
Ending balance	(635)		(635)
Unrealized Gains/Losses on Derivative Instruments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance			772
Other comprehensive income/(loss) before reclassifications			146
Amounts reclassified from AOCI			(1,183)
Tax effect			173
Total other comprehensive income/(loss)			(864)
Ending balance	(92)		(92)
Unrealized Gains/Losses on Marketable Securities
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance			(464)
Other comprehensive income/(loss) before reclassifications			69
Amounts reclassified from AOCI			149
Tax effect			(75)
Total other comprehensive income/(loss)			143
Ending balance	$ (321)		$ (321)

Benefit Plans - Additional Info

Benefit Plans - Additional Information (Detail) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Mar. 26, 2016	Mar. 28, 2015	Mar. 26, 2016	Mar. 28, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved for future issuance under stock plans (in shares)	377.3		377.3
RSUs granted vesting period			4 years
Fair value of vested RSUs as of vesting date	$ 450	$ 317	$ 2,500	$ 2,000
Stock options outstanding	1.1		1.1
Stock options, Weighted average exercise price per share	$ 15.48		$ 15.48
Stock options, Weighted average remaining contractual term			3 years 8 months 12 days
Stock options, Aggregate intrinsic value	$ 100		$ 100
Income tax benefit related to share-based compensation expense	347	$ 311	760	$ 662
Total unrecognized compensation cost on stock options, RSUs and restricted stock	$ 9,100		$ 9,100
Total unrecognized compensation cost on stock options, RSUs and restricted stock, weighted-average recognition period (in years)			2 years 10 months 24 days

Restricted Stock Units Activity

Restricted Stock Units Activity and Related Information (Detail) - Restricted Stock Units $ / shares in Units, shares in Thousands, $ in Millions	6 Months Ended
	Mar. 26, 2016USD ($)$ / sharesshares
Number of Restricted Stock Units
Beginning Balance | shares	101,467
Restricted stock units granted | shares	43,513
Restricted stock units vested | shares	(22,353)
Restricted stock units cancelled | shares	(2,413)
Ending Balance | shares	120,214
Weighted-Average Grant Date Fair Value Per Share
Beginning Balance | $ / shares	$ 85.77
Restricted stock units granted | $ / shares	110.57
Restricted stock units vested | $ / shares	78.86
Restricted stock units cancelled | $ / shares	93.43
Ending Balance | $ / shares	$ 95.80
Aggregate Intrinsic Value
Aggregate intrinsic value of Restricted stock units | $	$ 12,703

Summary of Share-Based Compensa

Summary of Share-Based Compensation Expense (Detail) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 26, 2016	Mar. 28, 2015	Mar. 26, 2016	Mar. 28, 2015
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	$ 1,048	$ 927	$ 2,126	$ 1,815
Cost of sales
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	191	142	395	282
Research and Development
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	468	384	934	758
Selling, General and Administrative
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	$ 389	$ 401	$ 797	$ 775

Changes in Accrued Warranties a

Changes in Accrued Warranties and Related Costs (Detail) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 26, 2016	Mar. 28, 2015	Mar. 26, 2016	Mar. 28, 2015
Movement in Standard Product Warranty Accrual [Roll Forward]
Beginning accrued warranty and related costs	$ 5,236	$ 5,195	$ 4,780	$ 4,159
Cost of warranty claims	(1,128)	(1,030)	(2,397)	(2,074)
Accruals for product warranty	877	978	2,602	3,058
Ending accrued warranty and related costs	$ 4,985	$ 5,143	$ 4,985	$ 5,143

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) $ in Millions	1 Months Ended	6 Months Ended
	Dec. 31, 2015USD ($)	Mar. 26, 2016USD ($)Store	May. 18, 2015USD ($)	Mar. 06, 2014USD ($)	Aug. 24, 2012USD ($)
Commitments and Contingencies Disclosure [Line Items]
Purchase commitments maximum period		150 days
Number of retail stores | Store		475
Total future minimum lease payments under noncancelable operating leases		$ 6,800
Samsung Electronics Co Ltd
Commitments and Contingencies Disclosure [Line Items]
Result of legal proceedings					$ 1,050
Award from legal proceeding			$ 548	$ 930
Proceeds from legal settlements	$ 548
Major Facility Lease | Maximum
Commitments and Contingencies Disclosure [Line Items]
Term of leases		10 years
Retail Space Lease
Commitments and Contingencies Disclosure [Line Items]
Total future minimum lease payments under noncancelable operating leases		$ 3,900
Retail Space Lease | Minimum
Commitments and Contingencies Disclosure [Line Items]
Term of leases		5 years
Retail Space Lease | Maximum
Commitments and Contingencies Disclosure [Line Items]
Term of leases		20 years
Retail Space Lease | Majority
Commitments and Contingencies Disclosure [Line Items]
Term of leases		10 years

Summary Information by Operatin

Summary Information by Operating Segment (Detail) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 26, 2016	Mar. 28, 2015	Mar. 26, 2016	Mar. 28, 2015
Segment Reporting Information [Line Items]
Net sales	$ 50,557	$ 58,010	$ 126,429	$ 132,609
Operating income	13,987	18,278	38,158	42,524
Americas
Segment Reporting Information [Line Items]
Net sales	19,096	21,316	48,421	51,882
Operating income	6,116	7,186	16,134	17,887
Europe
Segment Reporting Information [Line Items]
Net sales	11,535	12,204	29,467	29,418
Operating income	3,602	4,112	9,381	9,994
Greater China
Segment Reporting Information [Line Items]
Net sales	12,486	16,823	30,859	32,967
Operating income	4,818	6,714	12,394	13,080
Japan
Segment Reporting Information [Line Items]
Net sales	4,281	3,457	9,075	8,905
Operating income	1,930	1,699	4,170	4,187
Rest of Asia Pacific
Segment Reporting Information [Line Items]
Net sales	3,159	4,210	8,607	9,437
Operating income	$ 1,095	$ 1,600	$ 3,127	$ 3,449

Reconciliation of Segment Opera

Reconciliation of Segment Operating Income to Condensed Consolidated Statements of Operations (Detail) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 26, 2016	Mar. 28, 2015	Mar. 26, 2016	Mar. 28, 2015
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Operating income	$ 13,987	$ 18,278	$ 38,158	$ 42,524
Research and development expense	(2,511)	(1,918)	(4,915)	(3,813)
Operating Segments
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Operating income	17,561	21,311	45,206	48,597
Segment Reconciling Items
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Research and development expense	(2,511)	(1,918)	(4,915)	(3,813)
Corporate Non-Segment
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Other corporate expenses, net	$ (1,063)	$ (1,115)	$ (2,133)	$ (2,260)